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Summary 
 
The 21st century has seen the re-emergence of infectious diseases thought previously 
conquered by antibiotics. The human pathogen, Staphylococcus aureus, is one such 
example, with global reports listing resistance to antibiotics from methicillin to vancomycin, 
the so-called “drug of last resort”. The speed at which such pathogens acquire antibiotic 
resistance has led to the questioning of the current strategy of developing drugs that kill 
infectious agents directly. Instead, new tactics must be employed that rely more heavily on 
the host’s own immune defences. S. aureus circumvents the human immune system’s 
oxidative killing mechanisms through the actions of a thiol-disulfide interchange system 
which maintains intracellular redox balance within the pathogen. Disruption of the system 
and its players thus represents a potential target for the development of novel anti-
staphylococcal agents. This study set out to characterise three proteins suggested to be 
involved in the thiol-disulfide interchange system so as to assess their roles and their viability 
as effective drug targets. 
This study had two major aims: the functional characterisation of the MerA and YpdA flavin 
disulfide reductase homologs, and the assessment of the substrate promiscuity of the TrxB 
and TrxA proteins. The characterisation of MerA and YpdA involved activity assays with the 
LMW thiol disulfide substrates involved in S. aureus redox balance. While failing to show 
demonstrable disulfide reductase activity, MerA instead was found to have the ability to 
reduce two biologically-relevant transition metal ions without the aid of an interacting protein 
partner: Hg2+ and Fe3+. Fe3+ was further shown to be favoured over Hg2+ as a substrate of 
MerA, which has implications for the protein’s role in oxidative stress resistance. YpdA was 
shown to be incapable of reducing any of the LMW thiol disulfides found in S. aureus, even 
in the presence of a generic TFP protein, TrxA. This suggests that YpdA may be unable to 
perform catalytic functions in the absence of its correct interacting partner. Alternatively, the 
protein may perform a different cellular function unrelated to LMW thiol disulfide reduction or 
oxidative stress resistance.    
The substrate promiscuity of the thioredoxin system proteins of S. aureus, TrxB and TrxA, 
was demonstrated through their measurable reduction of three LMW thiol disulfides. 
However, the poor kinetic parameters determined for the reactions indicate that these 
proteins may be more likely to reduce the LMW thiol disulfides under critical conditions, as 
opposed to acting as their primary reducing system. Importantly, this study has 
demonstrated a role in the maintenance of S. aureus redox balance beyond the usual 
cellular functions of TrxB and TrxA. These findings provide additional support for TrxB as a 
viable target for the development of novel antibiotics. 
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Opsomming 
 
Die 21ste eeu het die terugkeer gesien van aansteeklike siektes wat voorheen deur 
antibiotika beheer kon word. Die menslike patogeen, Staphylococcus aureus, is een so 'n 
voorbeeld, met internasionale verslae wat weerstandigheid lys teen geneesmiddels van 
methicillin tot vancomycin, die sogenaamde "geneesmiddel van laaste uitweg". Die spoed 
waarteen sulke patogene weerstand ontwikkel teen antibiotika lei tot die bevraagtekening 
van die huidige strategie van geneesmiddels ontwikkel om bakterieë te dood. In teenstelling 
word nuwe taktiek benodig wat eerder staatmaak op die mens se eie immuunstelsel. S. 
aureus vermy die menslike immuunstelsel se oksidatiewe verdedigingsmeganismes deur die 
gebruik van 'n tiol-disulfied uitruilingstelsel wat intrasellulêre redoksbalans beheer binne die 
patogeen. Ontwrigting van die stelsel verteenwoordig dus 'n potensiële teiken vir die 
ontwikkeling van nuwe antistafilokokkale agente. Die doel van hierdie studie was om drie 
proteïene te karakteriseer wat betrokke is in die tiol-disulfied uitruilingstelsel, om sodoende 
hulle rolle te assesseer en hulle lewensvatbaarheid as teikens vir antibiotika te evalueer. 
Hierdie studie het twee hoofdoelwitte gehad: die funksionele karakterisering van die MerA en 
YpdA flavoproteïene, en die assessering van substraat-promiskuïteit van die TrxB en TrxA 
proteïene. Die karakterisering van MerA en YpdA het bestaan uit die uitvoering van 
aktiwiteitstoetse met die tiol disulfide substrate wat betrokke is in die handhawing van S. 
aureus se redoksbalans. Hoewel MerA geen bewese disulfide reduktase aktiwiteit 
gedemonstreer het nie, het die proteïen eerder die vermoë gedemonstreer om twee 
biologies-relevante metaal ione te reduseer sonder die hulp van 'n interaktiewe proteïen-
vennoot: Hg2+ en Fe3+. Fe3+ is verkies bo Hg2+ as 'n substraat van MerA, wat implikasies het 
vir die proteïen se rol in oksidatiewe stress-weerstand. Daar is bewys dat die YpdA proteïen 
geen van die tiol disulfiedes kon reduseer nie, selfs in die teenwoordigheid van 'n generiese 
TFP proteïen, TrxA. Dit dui daarop dat YpdA nie in staat mag wees om katalitiese funksies 
uit te voer nie, in die afwesigheid van die korrekte interaksie vennoot.  
Die substraat-promiskuïteit van die thioredoxin-sisteem proteïene van S. aureus, TrxB en 
TrxA, is gedemonstreer deur die meetbare redusering van drie tiol disulfied substrate. Tog 
dui die swak kinetiese parameters vir hierdie spesifieke reaksies daarop dat hierdie 
proteïene nie as primêre reduseeringsstelsel vir hierdie verbindings op te tree nie. Hierdie 
studie het 'n rol vir TrxB en TrxA in die handhawing van S. aureus redoksbalans 
gedemonstreer wat buite die proteïene se gewone sellulêre funksies is. Hierdie bevinding 
gee addisionele ondersteuning aan TrxB as 'n doeltreffende teiken vir die ontwikkeling van 
nuwe antibiotika.  
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Chapter 1 
Introduction to Staphylococcus aureus and the human 
immune system 
 
1.1 Staphylococcus aureus as a human pathogen 
 
Staphylococcus aureus is a pathogen primarily responsible for most purulent skin and soft 
tissue infections in humans. It is the main causative agent for a range of diseases, including 
epidermal abscesses, endocarditis and toxic shock syndrome.5, 6 Although the bacterium is 
commonly found on the skin and mucosal surfaces of 25-35% of healthy human beings15, it 
remains an opportunistic pathogen; S. aureus may invade and infect tissues wherever 
epithelial integrity is weakened, be it from injury or within the confines of medical procedures. 
As a result of this, S. aureus is a leading cause of both nosocomial and community-acquired 
infections.14  
1.1.2 The health threat posed by drug-resistant S. aureus 
 
The rising incidence of drug resistance within disease-causing bacteria is a worrisome 
threat. The 21st century has seen the rise of both new infectious diseases and the re-
emergence of those thought previously conquered by antibiotics, such as tuberculosis.12 S. 
aureus is no exception to the trend, having displayed formidable ability in acquiring 
resistance to multiple antimicrobial agents. The pathogen’s speedy evolution is apparent: in 
1946, S. aureus infections were readily treated with penicillin. Today however, more than 
50% of all S. aureus infections reported in the U.S.A are methicillin-resistant.15 Furthermore, 
many display additional resistance to second-line antibiotics, such as clindamycin and 
trimethoprim-sulfamethoxazole.4, 11 Most recently, reports of strains found to have resistance 
toward vancomycin, the so-called “drug of last resort”, have been on the rise worldwide.8, 15 
The incidence of methicillin-resistant S. aureus (MRSA) is also troublingly common in many 
countries across the globe, ranging from 10% - 50% of the total reported S. aureus infections 
(Figure 1.1). The evidence provided in these statistics is clear:  utilising antibiotics that 
directly kill pathogens does not work in the long-term. Rather, this strategy promotes 
antibiotic resistance and thus creates pathogens that are more formidable. In order to 
combat this rise in drug resistance, new tactics must be employed that rely more heavily on 
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the host’s own immune defences. New antibiotics should thus weaken the bacterium, or 
alternatively strengthen the host immune system so that it may handle the infection alone.  
 
 
1.2 Reactive oxygen species and their role in the host immune response   
 
Despite its necessity to and use in many metabolic processes, oxygen is a highly reactive 
molecule. Partial reduction of oxygen leads to the formation of reactive oxygen species 
(ROS), most notably hydrogen peroxide (H2O2), superoxide (O2•-) and hydroxyl radicals 
(OH•).7 
These reactive species can cause extensive damage to proteins, lipids and DNA if not dealt 
with, and as a result of this, all aerobic organisms are equipped with various systems for 
neutralising and eliminating moderate exposure to ROS. The human innate immune system 
takes advantage of oxygen’s toxicity, directly attacking pathogens with a blast of ROS in 
order to eliminate them from the host.5, 16 Bacterial pathogens must therefore be capable of 
surviving two distinct sources of ROS: those generated through normal cellular metabolism, 
and those used by immune defences as a form of attack.   
Figure 1.1: Global prevalence of hospital acquired MRSA infections in 201215 
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1.2.1 Sources of ROS 
1.2.1.1 ROS from the electron transport chain 
 
The electron transport chain (ETC) in bacteria is used to produce ATP via the movement of 
electrons. Electrons obtained from metabolic components, such as NADH and FADH2, are 
channelled through four membrane-embedded complexes, with O2 serving as the final 
electron acceptor. The energy that is released through electron movement down a reduction 
potential is used to create the H+ gradient that drives ATP production.13 
Imperfections in the system however, lead to the minor production of O2•-. Electrons are 
capable of leaking into the periplasmic space from complexes I and III of the ETC, at which 
point they will reduce the O2 present there (Figure 1.2A). The ETC alone is responsible for 
converting up to 2% of the oxygen consumed by the cell into O2•-. In order to mitigate any 
oxidative damage, any O2•- produced is neutralised by superoxide dismutase (see chapter 
2).13   
1.2.1.2 ROS from the NADPH-oxidase complex 
 
When an infection is detected within the host, cytokines are released by the inflamed 
epithelium, thus drawing phagocytic macrophages and neutrophils to the site.16 
Consequently, the pathogen will be engulfed by these cells and subjected to a combination 
of both oxidative and non-oxidative killing mechanisms. The former relies on the generation 
of ROS by a phagocytic NADPH-oxidase complex (NOX), whilst the non-oxidative methods 
include the use of degradative proteases.1, 16  
While the neutrophil is at rest, most NOX complexes are located on the membranes of 
intracellular granules, with only 10-20% found on the cellular plasma membrane.17 Upon 
recruitment of the neutrophil to the infection site, granules will fuse with the phagosome 
membrane encasing the pathogen, thus further enriching the membrane with NOX 
complexes. Prior to O2- generation, NOX must be activated through the association of a FAD 
cofactor to the enzyme.13 Various NOX complexes exist within neutrophils, each with 
different cell or tissue-specific expression patterns dictating a particular enzymatic core 
(NOX 1-5, Duox 1 or Duox 2). Different complexes may additionally require particular 
cofactors for activation, such as bound calcium or specific proteins (Figure 1.2B).1, 13  
NOX assembled on the phagosome generates O2•- by channelling electrons acquired from 
cytoplasmic NADPH through complex-bound FAD and two heme b prosthetic groups.13 The 
electrons will move across the phagosomal membrane via the above-mentioned electron 
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carries, finally passing from heme to molecular oxygen, creating O2•-. The O2•- may be further 
dismutated (either spontaneously or via SOD) to form H2O2 and molecular oxygen.13, 19 
Additionally, any H2O2 and O2•- generated by NOX complexes at the neutrophil plasma 
membrane may move across the phagosome (via diffusion or anion channels respectively) 
in order to attack the bacterial target.13, 17 
 
Figure 1.2: The sources of ROS. A) The electron transport chain (illustrated here for 
mitochondria) converts up to 2% of the oxygen consumed by the cell into O2. This occurs 
when electrons leak from complexes I and III into the intermembrane space outside of the 
cell membrane. The electrons will then be used to reduce O2 to O2. B) Activated NADPH 
oxidase assembles at both the neutrophil cell membrane (pictured here) and the phagosome 
membrane to generate O2. Electrons from cytoplasmic NADPH are donated to the FAD 
moiety of the complex and are passed through two heme groups before reducing O2. A 
portion of the O2 generated may then be further dismutated to H2O2. Figure reproduced from 
Paulsen et al.13 
A 
B 
Stellenbosch University  http://scholar.sun.ac.za
 5 
 
1.2.2 Other oxidants  
 
In addition to ROS, phagosomes are capable of producing hypohalous acids (HOX) that are 
further detrimental to invading pathogens. HOXs may be produced through the reaction of a 
halide ion (Cl-, Br- or I-) with H2O2, which is catalysed by the enzyme myeloid peroxidase.13, 16 
The oxidation of any particular halide ion results in the formation of its corresponding HOX, 
e.g. hypochlorous acid (HOCl) is produced though the oxidation of Cl- with H2O2.13 
HOXs are potent bactericidal compounds, readily oxidising any thiol groups or methionine 
residues they come into contact with. In addition to this, HOCl specifically may react with O2•- 
to produce OH•. This is extremely problematic for the bacterial cell, as OH• is a powerful 
radical to which the cell has no specific enzyme antioxidants.13, 16   
1.2.3 Fenton chemistry and ROS 
 
Within bacterial cells, H2O2 and O2•- may react with various trace metal ions to produce OH• 
as a result of the Haber-Weiss reaction and Fenton chemistry as follows:18 
Haber-Weiss Reaction: 
Fe3+ + O2•-               Fe2+ + O2 
Fenton Reaction: 
Fe2+/Cu+ + H2O2               Fe3+/Cu2+ + OH- + OH• 
Net reaction: 
H2O2 + O2•-                OH- + OH• + O2 
Although this phenomenon is not directly utilised by the immune system, it is nonetheless 
important for its added detrimental effect on the pathogen. Thus the neutrophil need only 
generate H2O2 and O2-, whilst the natural chemical reactions between these ROS and trace 
metals within the bacteria will lead to the additional production of OH•.      
1.2.4 The effects of ROS and oxidants on the bacterial cell 
 
The ROS and other oxidants produced by the neutrophil will proceed to oxidise lipids, DNA 
and, critically, the thiol groups of any cysteine residues found in the proteins of bacterial 
pathogens.3, 9, 16 The oxidation of these thiol groups leads to the formation of sulfenic acids 
and, if allowed to continue, the original thiols will be irreversibly oxidised to sulfinic and 
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sulfonic acids (Figure 1.3).3, 19 This creates irreparable damage to the proteins essential to 
the pathogen’s survival. In combination, these processes all contribute to the toxic effects of 
oxidative stress that will cumulatively cause the bacteria to die if they do not employ 
mechanisms to resist these effects. 
 
Figure 1.3: The effects of ROS exposure on protein thiol groups. Initial exposure of reduced 
protein thiol groups (A) to ROS leads to the formation of a sulfenic acid (B). Sulfenic acid 
may still be converted back to an ordinary thiol group. However, prolonged exposure to ROS 
leads to irreversible oxidation through the formation of sulfinic and sulfonic acids (C and D 
respectively). 
 
1.3 Focus of this study 
 
S. aureus, like many other organisms, employ several specific mechanisms to counter 
oxidative stress. However, in its case these mechanisms are even more crucial as it ensures 
the survival of these bacteria within the human host by naturally countering the oxidative 
killing mechanisms of the human immune system. As such, these mechanisms can be 
considered as attractive targets for the development of novel drugs; by disabling the system, 
S. aureus would be made more vulnerable to destruction by the body’s own immune 
response. However, we do not yet understand the exact mechanisms and components 
involved in these resistance mechanisms well enough in order to exploit it.  
1.3.1 Aim and objectives of this study 
 
The two main aims of this study was to 1) functionally characterize the putative flavin 
disulfide reductase (FDR) enzymes MerA and YpdA, and 2) to assess the substrate 
promiscuity of the FDR TrxB and its thioredoxin fold protein (TFP) partner, TrxA. These 
proteins, MerA, YpdA, TrxB and TrxA, may be involved in maintaining the redox balance in 
S. aureus through thiol disulfide interchange reactions.  
Stellenbosch University  http://scholar.sun.ac.za
 7 
 
These aims were be achieved by pursuing the following objectives: 
1. Performing the cloning of the genes encoding the MerA, YpdA, TrxB and TrxA 
proteins.   
2.  Expression and purification of these four proteins 
3. Executing an activity characterization of the MerA and YpdA proteins to determine 
their native substrates and oxidative stress-related function(s). 
4. Assessing substrate promiscuity in the TrxB and TrxA proteins, as well as 
understanding the relevance thereof in S. aureus oxidative stress resistance. 
In this manner, this study intends to provide a better understanding of S. aureus’s ability to 
resist oxidative stress, and to thereby lay the foundation for the development of novel anti-
staphylococcal agents. 
1.3.2 Outline of the thesis 
 
The thesis consists of 5 chapters. The first chapter provides an overview of the study and 
states its aim and objectives. This is followed by a detailed review of our current knowledge 
of the S. aureus oxidative stress resistance mechanisms. Chapter 3 will discuss the 
purification and functional characterisation of the MerA and YpdA FDR proteins. Chapter 4 
will detail the purification of the TrxB and TrxA protein system, as well as all experimental 
procedures indicating enzyme-substrate activity. The final chapter 5 will provide a summary 
of the findings in this study and detail any future work.  
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Chapter 2 
Oxidative stress resistance mechanisms of 
Staphylococcus aureus: 
A review of the current knowledge 
 
2.1 Introduction  
 
Our current knowledge of S. aureus physiology indicates that this organism is capable of 
resisting oxidative stress via the orchestrated action of two distinct systems. As a first 
response, oxidative stress is dealt with directly by ROS-eliminating enzymes. These include 
superoxide dismutases to engage superoxide, whilst catalase and peroxiredoxins (the latter 
of which are thioredoxin-fold proteins or TFPs) degrade hydrogen peroxide.6, 7 However, 
while these enzymes can neutralise ROS, they cannot reverse any damage that the reactive 
molecules may have caused. Therefore, S. aureus employs a tight-knit thiol-disulfide 
interchange system to reduce any oxidised cysteine residues in proteins.43   
The aim of this chapter is to clearly outline the current knowledge regarding these systems, 
the various actors that are involved in them and their potential roles and interactions.  
2.2 Mechanisms that directly eliminate ROS 
2.2.1 Superoxide dismutase 
 
Superoxide dismutases (SOD) are metalloproteins that catalyse the dismutation of O2•- to 
H2O2 and the release of O2 in the process.4, 7, 24 These enzymes act as the first line of 
defence against ROS, converting O2•- to H2O2, which in turn may be detoxified by catalase 
and peroxiredoxins.4, 7 The role of SODs in bacterial oxidative stress resistance is therefore 
crucial: the enzymes protect the cell against direct damage inflicted by O2•-, but also 
indirectly prevent the formation of OH•- (via the Haber-Weiss reaction of O2•- with Fe3+.31, 40 S. 
aureus is known to possess two superoxide dismutases; SodA and SodM, both of which 
utilise manganese as their metal cofactor.8 Various studies have indicated that SodA is the 
primary superoxide dismutase of S. aureus, as mutants lacking sodA display greater 
superoxide sensitivity and growth defects than sodM mutants. However, both enzymes will 
function in concert to dismutate external sources of O2•-.5, 6   
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2.2.2 Catalase  
 
H2O2 possesses the longest half-life of the primary ROS (milliseconds versus the nano- and 
pico-second half-lives of OH- and O2- respectively).24 This is due to the high stability of the 
molecule’s oxygen-oxygen bond, which requires high activation energy in order to be 
broken, and the absence of any unpaired electrons. However, the O-O bond may be 
weakened by interaction with transition metals, most notably iron.5, 22 
The primary function of the catalase enzyme is the decomposition of H2O2 to H2O and O2, 
thus protecting the cell against detrimental oxidation.22, 24 The enzyme is a homotetramer, 
containing one heme group per subunit. The heme prosthetic group found within catalase 
plays a very significant role in the enzyme’s ability to break down H2O2, as the O-O bond of 
H2O2 may be weakened by iron.5, 22 The reversible interaction of heme and H2O2 causes 
catalase to decompose H2O2 in two distinct steps Figure 2.1)22:  
1.) The heme iron is oxidised by H2O2, forming an enzyme-substrate intermediate often 
referred to as “compound I”. 
2.) A second H2O2 molecule is recruited to act as an electron donor to compound I, thereby 
regenerating the heme iron and allowing for the release of the final products, H2O and O2.  
As the second line of defence after SOD, catalase is responsible for fully neutralising the last 
of the ROS from the cell. Although H2O2 is the mildest and slowest of oxidants, its extended 
presence in the cell poses an integral threat until removed. Following the final elimination of 
all ROS, the bacterium may deploy the thiol-disulfide interchange system components to 
handle any oxidative damage sustained.  
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Figure 2.1: The neutralisation of H2O2 by catalase. The heme group of catalase is integral to 
the enzyme’s mechanism of action, allowing for the formation of the “compound I” 
intermediate. Scheme modified from Nicholls et al.22 
 
2.2.3 Peroxiredoxins  
 
Peroxiredoxins (Prxs) are thioredoxin-fold proteins (TFPs) that contain reactive cysteine 
residues that react with hydrogen peroxide to form sulfenic acid residues, and water.16 While 
these proteins therefore also directly eliminate ROS, they can only do so catalytically if their 
oxidised forms are reduced 43; this occurs by means of the thiol-disulfide interchange 
systems. They are therefore described in more detail together with other role players in this 
system (see section 2.3.2.3 below).   
2.3 Redox balance maintenance through thiol-disulfide interchange reactions  
 
The S. aureus thiol-disulfide interchange system makes use of low molecular weight (LMW) 
thiols, thioredoxin fold proteins (TFPs) and flavoprotein disulfide reductases (FDRs) to assist 
in the maintenance of a reduced intracellular environment. The role players of the thiol-
disulfide interchange systems—like the Prxs mentioned above—must be constantly returned 
to a reduced state in order to function (Figure 2.2).43  
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Figure 2.2: The effects of, and protection against, ROS on intracellular proteins. The initial 
reaction of a protein thiol groups with ROS leads to the formation of a sulfenic acid (A). 
Whilst sulfenic acid may be converted back to a normal thiol, prolonged exposure to ROS 
will lead to the formation of sulfinic and sulfonic groups (B and C). These groups are 
irreversible once formed, and the entire protein would need to be destroyed. In order to 
avoid this, LMW thiols are employed to form mixed disulfides with the thiol groups of 
proteins. The disulfide is protected from oxidation, and may be easily converted back to its 
original state via the thiol-disulfide interchange system.  
 
When the bacterial cells are subjected to a blast of ROS by the human native immune 
response, they must be capable of both neutralising the reactive compounds and mitigating 
any damage they cause. For the former, the ROS-neutralising enzymes eliminate reactive 
intermediates. In order to avoid the crippling loss of essential enzymes and proteins, the 
cells rely on the working of the thiol-disulfide interchange system. 
The thiol-disulfide interchange system serves the dual functions of protecting protein thiol 
groups from irreversible oxidation and restoring them to their native reduced state. LMW 
thiols may react with the sulfenic acid formed from initial ROS exposure, creating a mixed 
protein-LMW thiol disulfide. This process, known as S-thiolation, prevents the formation of 
irreversible sulfinic and sulfonic acids.29 Once the cell has successfully eliminated the ROS, 
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the mixed disulfide must then be returned to its original reduced state through the action of 
FDRs and/or TFPs. Reversal of the S-thiolation is achieved in one of two possible ways29, 43 
(Figure 2.3):  
• The TFP may act first, transferring electrons (via the corresponding FDR) from 
NADPH to the disulfide bond between LMW thiol and protein, thus reducing it.  
• Alternatively, the mixed disulfide bond may be reduced by an FDR directly, with 
NADPH again serving as the final electron donor in the process. 
This system therefore insures that the intracellular proteins are both protected from 
irreparable damage, and returned to their original reduced state. The wasteful elimination of 
damaged proteins is thus kept to a minimum, and the bacterial cell may rapidly recover from 
the stresses endured. 
However, our understanding of the thiol-disulfide interchange system of S. aureus remains 
incomplete. Whilst several players involved in the system have been assigned function, 
substrates and even interacting protein partners, many remain shrouded in the unknown. 
Structural analyses of the uncharacterised proteins have been taken together with an 
understanding of the general mechanisms whereby this system functions. This information 
has created a tentative roadmap whereby hypotheses surrounding uncharacterised proteins 
may be made. In the following section our current knowledge of these various role players 
will be reviewed. 
2.3.1 The LMW thiols  
 
S. aureus has been found to rely on two major LMW thiols for redox balance maintenance 
and xenobiotic detoxification: Coenzyme A (CoA) and bacillithiol (BSH).20, 21 This is contrast 
to most other organisms, which uses glutathione for these processes. However, S. aureus 
does not produce nor utilize this compound.20, 28 
CoA has been extensively researched for its roles in S. aureus redox homeostasis, while 
BSH was only recently discovered in S. aureus.21 The roles and known interactions of these 
LMW thiols in the organism’s redox physiology are described below. Several other LMW 
thiols — such as cysteine, pantetheine and lipoamide — are also found in S. aureus,8, 35 but 
are not discussed in detail here since none of them have been implicated as being involved 
in maintaining its redox homeostasis to date. Cysteine in particular cannot practically be 
employed as a redox buffer due to its toxicity at high intracellular concentrations.8, 35 This 
toxicity stems from the phenomenon of rapid metal-catalysed auto-oxidation of cysteine in 
the cytoplasm, ultimately leading to the production of cystine and H2O2.3, 35 Lipoamide, on 
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the other hand, is usually physically bound to the protein that utilises it as a cofactor, and is 
therefore not considered as likely to interact with proteins other than its identified partners.18, 
27
  
2.3.1.1 CoA  
 
The role of CoA in S. aureus was first brought to light in a study by Newton et al.20 The study 
demonstrated that S. aureus does not synthesise the LMW thiol glutathione (GSH), and thus 
does not employ it for redox balancing mechanisms. Rather, the bacteria were found to 
produce millimolar quantities of coenzyme A (CoA), suggesting that the compound is the 
predominant thiol in S. aureus.20, 35  
Like GSH, CoA is resistant to metal-catalysed oxidation, and was also discovered to 
possess a dedicated FDR, CoA disulfide reductase, to maintain its reduced state.8, 35 
However, unlike GSH, CoA cannot function as a reservoir from which Cys may be 
regenerated. Furthermore, the importance of CoA in S. aureus was demonstrated in a 2004 
study by Leonardi et al.17 The biosynthesis of CoA in S. aureus was found to be resistant to 
feedback inhibition by CoA or any of its thioester derivatives, thus allowing the cell to 
maintain the millimolar concentrations of the cofactor required for redox homeostasis.17 
Research into the natural antibiotic CJ-15,801 has provided more evidence to the 
importance of CoA in S. aureus. CJ-15,801, a structural homolog of pantothenic acid, was 
found to specifically inhibit the growth of S. aureus by targeting its CoA biosynthetic 
pathway.34, 36 The compound achieves this by irreversibly inhibiting the enzyme 
phosphopantothenoylcysteine synthetase (PPCS), which catalyses the second step of CoA 
biosynthesis.37 The evolution of a natural compound like CJ-15,801 is thus a testament to 
the importance of CoA to S. aureus’s survival; interruption of CoA biosynthesis is visibly 
detrimental to cell growth, making the pathway an obvious target. 
Reviewing the information discussed, strong evidence is apparent for the importance of CoA 
in S. aureus. The maintenance of CoA at millimolar intracellular concentrations, the 
bacteria’s lack of GSH and the negative effects observed during interruption of CoA 
biosynthesis; taken together, this information underscores the important role played by the 
thiol in S. aureus.       
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Figure 2.3: The general mechanisms of action for the thiol disulfide interchange 
proteins. The FDR protein may act either alone or in concert with its corresponding TFP 
partner to reduce the mixed LMW thiol protein thiol disulfide. When acting together, the TFP 
will reduce the mixed disulfide, becoming oxidised in the process. It will be returned to its 
reduced state through the action of its corresponding FDR. NADPH will donate electrons to 
the FAD subunit of the FDR, which in turn will reduce the oxidised active site Cys residues of 
the FDR. When acting without a TFP, the FDR acts directly upon the mixed disulfide. The 
resulting oxidised FDR will once again be returned to a reduced state via NADP and FAD. 
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Figure 2.4: The major bacterial LMW thiols. Glutathione is the primary redox-active LMW 
thiol of eukaryotes and Gram-negative bacteria. Gram-positive bacteria however, contain 
several different LMW thiols among different species or classes. Mycothiol is utilised by the 
Actinobacteria, whilst bacillithiol may be commonly found within the phylum Firmicutes. CoA 
appears to act as the primary redox-active LMW thiol in several Gram-positive species of 
bacteria. Figure modified from Bui Khan, 2013.3  
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2.3.1.2 BSH  
 
Bacillithiol was first reported by two independent studies as an unknown LMW thiol in 
Bacillus species.20, 21 Following the efforts of multiple collaborating researchers, it was 
structurally characterised and designated as bacillithiol, or BSH.21 Although BSH is currently 
considered to be the major LMW thiol of most Bacillus species, it has also been found to be 
present in most Staphylococcus aureus strains.32 Its structural analogy to mycothiol (the 
major LMW thiol of the Actinomycetes) has led to the hypothesis that BSH may play a 
significant role in the oxidative stress response of the bacteria that possess it.13, 32 Studies by 
Rajkarnikar et al. on S. aureus BSH-null mutants sought to explore the role of the LMW thiol 
in these bacteria. S. aureus BSH-null cells, similar to their B. subtilis counterparts, show 
increased sensitivity to thiol-oxidising reagents, reactive electrophiles, toxic metal ions & 
metalloids, and the antibiotics fosfomycin and rifamycin.32 Furthermore, when treated with 
cumene hydroperoxide and H2O2, BSH-null mutants proved to be very sensitive to oxidative 
stress. While these results are good indicators that BSH may be involved in maintaining S. 
aureus redox homeostasis, the exact role of the thiol in this process is uncertain.  
A study by Pother et al. revealed certain strains of S. aureus that do not produce BSH, 
specifically the NCTC 8325 lineage and its descendents.28 This is due to an 8 bp duplication 
in the bshC gene, which encodes the BSH-biosynthetic protein BshC. In accordance with the 
Rajkarnikar study, these natural BSH-null strains were found to be more sensitive to 
fosfomycin thiol-oxidising compounds such as hypochlorite.28 Conversely, no difference was 
observed between the BSH-producing and BSH-lacking cells when exposed to diamide or 
H2O2.28 However, the latter observation was performed under ideal cell culture conditions , 
and could lead to misleading interpretations. More appropriate results have been derived 
from observations that BSH-deficient S. aureus cells in the mouse macrophage model 
displayed greatly decreased viablility.28 These results together suggest that while S. aureus 
strains that are naturally unable to synthesise BSH are able to cope with oxidative stress, 
they do not do so nearly as well as those that do synthesise it. These results imply that BSH 
is not an essential LMW thiol for oxidative stress resistance in S. aureus. Rather, it may act 
as a back-up system in strains that can produce it, whilst also providing further virulence 
through fosfomycin resistance.      
2.3.2 The thioredoxin fold proteins (TFPs) 
 
The thioredoxin fold proteins are a class of protein superfamily linked by their use of a 
thioredoxin domain: a four-stranded β-sheet sandwiched by three α-helices.2 A second 
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feature routinely shared among the TFP class is the presence of a CxxC active site 
associated with disulfide reduction. The latter, although not a ubiquitous feature, is 
commonly seen among the TFPs. TFPs are found in almost every living organism, and serve 
various functions, most often oxidative stress defence, assisting in protein folding, the 
formation/reduction of disulfide bonds and the elimination of xenobiotics.2 The TFPs 
discussed in this section are primarily involved in redox balance and combatting oxidative 
stress in bacterial cells. 
2.3.2.1 Thioredoxin (S. aureus TrxA)  
 
Thioredoxin (Trx) is a multifunctional, LMW oxidoreductase possessing an active site 
containing two Cys residues. The most characteristic feature of all Trx proteins is that these 
residues are contained in a highly conserved CGPC motif.16 The motif’s Cys pair is essential 
to Trx function; Trx reduces its disulfide-containing substrate (often a disulfide-containing 
protein), by thiol-disulfide interchange, which  results in the oxidation of its Cys residues.14, 16 
The reducing equivalents released in the process are thus donated to the substrate, and the 
Cys-pair of Trx forms a resultant disulfide bridge. Trx will subsequently be returned to its 
reduced state by thioredoxin reductase (TrxR) via a NADPH-dependent reaction (Figure 
2.5). Hence, all Trx proteins rely on TrxR to return to a reduced state.1, 14 
For bacteria that do not make use of the glutathione/glutathione reductase system, the Trx-
TrxR system is possibly the most crucial for maintaining intracellular redox regulation. The 
system is capable of reducing a wide variety of substrates simultaneously, while Trx alone 
has also been found to be involved in a number of diverse cellular functions, e.g. providing 
electrons to enzymes such as ribonucleotide reductase and methionine sulfoxide reductase.1 
The importance of Trx to the on-going survival of S. aureus, and indeed its success as a 
human pathogen, cannot be underestimated.       
2.3.2.2 Peroxiredoxin  
 
Peroxiredoxins (Prx) form part of a class of antioxidant enzymes known as the alkyl 
hydroperoxide reductases16. These proteins catalyse the direct reduction of H2O2 and 
organic hydroperoxides. The Prx system displays great similarity to the Trx system: most 
Prxs possess a similar active site CxxC motif that is required to carry out reduction of the 
substrate.25, 41 Additionally, the oxidised Prx relies on a NADPH-dependent reaction with its 
corresponding peroxiredoxin reductase (PrxR) to return to the reduced state. Peroxiredoxins 
may fall into one of three classes: typical two-cysteine, atypical two-cysteine and typical one-
cysteine Prxs.41 Typical and atypical two-cysteine both contain two redox active Cys 
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residues, with the former presenting as a homodimer, whilst the latter is monomeric. Typical 
one-cysteine Prxs most likely require an exogenous thiol-containing electron donor with 
which to form a disulfide after reducing the substrate, although this has yet to be 
experimentally verified.16, 41  
The bacterial Prx, AhpC, is a typical two-cysteine Prx that functions with the PrxR, AhpF, in 
order to reduce peroxides. Although AhpC has been shown to demonstrate a lower catalytic 
efficiency towards H2O2 than that of bacterial catalase (105 M-1s-1 vs. 106 M-1s-1 respectively), 
it plays an important role in the detoxification of endogenously-produced peroxides.16, 41 
2.3.2.3 Glutaredoxin (and other LMW thiol-dependent redoxins)  
 
Glutaredoxins (Grx) are glutathione-dependent oxidoreductases.16 Consequently, no 
examples of such proteins exist in S. aureus, as it contains no glutathione.20 However, this 
family of proteins serve as a model for the interplay between a TFP and a LMW thiol, and as 
such will be discussed in detail here to provide background for the putative bacilliredoxins 
that might exist in S. aureus.  
The Grx family of proteins share a number of characteristics with Trx: like Trx, they are 
proteins of a low molecular weight and are capable of acting upon a range of disulfide-
containing substrates.16 However, the pathway of electron transfer in the Grx system is 
strikingly different from that employed by Trx (Figure 2.5). 
The Grx pathway functions as follows16: 
• Much like the Trx protein, Grx directly reduces a protein disulfide substrate, 
becoming oxidised in the process. 
• The oxidised Grx is returned to the reduced state by GSH. This is in contrast to the 
oxidised Trx protein, which is reduced by a dedicated TrxR. 
• The oxidised GSH (GSSG) is reduced by glutathione reductase (GR) in an NADPH-
dependent reaction. 
In addition to the different mechanism of action, Grx proteins are capable of functioning as 
either monothiol or dithiol enzymes, depending on the number of redox-active Cys residues 
present in the active site.16 The monothiol Grx protein catalyses the reduction of mixed 
disulfides, specifically those of gluthionylated proteins. Dithiol Grx is capable of reducing a 
range of protein disulfides, and thus acts as a moonlighting redox-balance protein.16 
For many species, the Grx/GSH/GR system is the primary means of combating oxidative 
stress and maintaining redox homeostasis. However, as stated above, S. aureus does not 
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contain GSH, and similarly lacks any Grx and GSSGR enzymes. Instead, the analogies 
drawn between BSH, GSH and the primary LMW thiol of the Actinobacteria, MSH, have led 
to the proposed existence of a “bacilliredoxin” (Brx) by Helmann.13 Such a Brx-dependent 
system has been suggested to act as a functional replacement for the Grx/GSH/GSSGR 
system in bacteria which lacks this LMW thiol. Furthermore, such a suggestion also implies 
the existence of a dedicated BSSB reductase of sorts. Thus, Brx proteins could potentially 
reduce mixed protein disulfides with BSH and a BSSB reductase (Figure 2.5). To date, no 
CoA-redoxins have been identified. 
 
Figure 2.5: Grx vs. Trx mechanisms of action. A) Trx proteins reduce the mixed 
disulfide/protein disulfide substrate directly and are restored to the reduced state by the 
corresponding TrxR. B) Grx proteins also act directly upon the protein disulfide substrate. 
However the resulting oxidised Grx will not be reduced by a Grx disulfide. Instead, the 
oxidised Grx protein will be reduced by interaction with the LMW thiol GSH, which in turn is 
reduced by a dedicated glutathione reductase. C) A potential mechanism of action for the 
hypothesised “Brx/BSH/BSSB reductase system, based on the GSH model. Scheme 
adapted from Kalinina et al.16 
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2.3.2.4 Putative bacilliredoxins 
 
Through phylogenomic profiling, a recent study by Gaballa et al. revealed a number of 
potential bacilliredoxins.10 The study utilised the EMBL STRING programmes to identify four 
conserved genes that occur with high frequency in the genomes of BSH-synthesising 
bacteria. The proteins of the genes identified are as follows: YpdA (a TrxR homolog, see 
section 2.3.4.3), YphP (a putative Trx-like protein), YqiW and YtxJ (a Grx-like protein).10  
The yqiW and yphP genes are paralogues, thought to have both derived from the same 
ancestral gene and displaying 53% DNA sequence identity with one another.10, 13 YqiW and 
YphP both belong to the DUF1094 protein family, characterised by their small size (±145 aa) 
and unknown function. DUF1094 proteins commonly occur in pairs that are widely 
conserved in BSH-producing Firmicutes. Although the YqiW and YphP proteins display 
several structural similarities to Trx proteins, both lack the critical active site CxxC motif. 
Instead, the proteins have a variant CxC sequence. YphP and YqiW have instead been 
suggested to potentially function as disulfide isomerases for BSH-related activities.13  
In contrast, the YtxJ protein contains only a single conserved Cys residue, in a motif much 
like that seen in monothiol Grx. Previous studies have demonstrated that the expression 
YtxJ is induced by oxidative stress, although its role remains undiscovered.10 
 
2.3.3 The flavoprotein disulfide reductases (FDRs) 
 
The flavoprotein disulfide reductases are a group of proteins that catalyse oxidation and/or 
reduction reactions using a wide range of substrates. The FDRs are united by the presence 
of two dinucleotide binding domains in the form of Rossmann folds.23 Whilst one domain 
always binds a FAD moiety, the other is capable of binding a pyridine nucleotide, i.e. either 
NADH or NADPH. The FDRs may be classified within one of three subgroups: the disulfide 
reductases (DSR), the alkylhydroperoxide reductases (AHR) or the peroxidase/oxidase 
subgroup (POR).23  
2.3.3.1 CoA disulfide reductase (CoADR) 
 
CoA disulfide reductase (CoADR) is a dimeric flavoprotein primarily responsible for the direct 
FDR-only reduction of CoA disulfide in S. aureus (Figure 2.3).8, 35 At first glance, CoADR is 
structurally similar to proteins from the pyridine nucleotide disulfide oxidoreductase 
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(PNDOR) superfamily: it possesses two FAD-binding regions, one NADPH-binding region 
and a catalytic site, all of which are spatially organised similarly to proteins of the 
superfamily. Crucially lacking however, is a conserved pair of active site cysteine residues.8, 
35
 Instead, CoADR possesses only one Cys residue within the active site, whilst a second is 
found in the N-terminal βαβ motif. Despite the presence of a second Cys, the active site Cys 
residue alone is involved in any catalytic redox activity.8, 35 
The single active site Cys residue of CoADR has drawn much interest. The Cys residue 
forms part of a SFxxC motif, most commonly seen in enzymes such as NADH oxidase or 
NADH peroxidase, which catalyse the formation and inactivation of H2O2 respectively.8, 35 
Prior to discovery of the motif in CoADR, its presence was thought to indicate a role in the 
reduction of O2 or a derivative thereof (e.g. H2O2). However, the appearance of the motif in a 
LMW thiol reductase suggests that it is indicative of a disulfide reductase. 
Due to the crucial role of CoA as the primary LMW thiol active in maintaining S. aureus 
redox balance (see section 2.3.1.1), the equal importance of the CoADR enzyme must be 
emphasised as the dedicated FDR responsible for maintaining the reduced status of this 
LMW thiol. In spite of this central role, the inhibition of CoADR is not lethal to S. aureus as 
the cdr gene encoding the FDR is actually non-essential under normal growth conditions.8, 37 
However, the inhibition of CoADR could still have catastrophic consequences for the cell 
during oxidative stress, although this has not specifically been investigated. Naturally, 
investigations into the development of CoADR inhibitors have therefore drawn some interest. 
The synthesis of the first CoADR inhibitors was carried out by van der Westhuyzen et al., 
leading to the creation of four CoA analogues.37 These analogues acted as competitive, 
irreversible inhibitors of CoADR through the modification of the single active site Cys 
residue. These inhibitors represent an important step in the work towards novel anti-
staphylococcal agents targeting cellular redox balance.  
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Figure 2.6: Michael-acceptor CoA and pantothenic acid analogs as inhibitors of CoADR. 
The CoA analogs designed by van der Westhuyzen et al. (B) are competitive inhibitors of 
CoADR. However, these compounds are too polar for cellular application, and thus their 
pantothenamide analogs (A) may be utilised. These compounds may cross the cell 
membrane and are converted to active CoA inhibitors by CoA biosynthetic enzymes. 
Scheme modified from van der Westhuyzen et al.37  
 
 2.3.3.2 Thioredoxin reductase (S. aureus TrxB) 
 
The thioredoxin reductase enzyme (TrxR) is a NADPH-dependent homodimeric 
oxidoreductase that reduces the active centre disulfide of oxidised Trx. TrxR contains a 
CxxC active site motif and one FAD molecule per subunit, both of which are critical to its 
reducing abilities. Together with NADPH, Trx and TrxR act as a powerful protein disulfide 
reductase system in most species that is capable of reducing a range of protein and LMW 
thiol disulfides in a non-specific manner.1, 14, 16  
The TrxR protein is essential to the survival of any living cell, with previous research efforts 
demonstrating that any attempts to create trxR-null cells promptly lead to cell death.30 This is 
most likely due to the crucial role played by the thioredoxin system in DNA synthesis; Trx 
and TrxR channel redox equivalents to the class 1b ribonucleotide reductase, an enzyme 
centrally involved in DNA synthesis.1, 14 Furthermore, the “promiscuity” of all TrxR proteins is 
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well-documented. TrxR proteins have been demonstrated to interact with a wide range of 
substrates and other proteins, as well as fulfil several different roles in cellular function.1, 16 
The thioredoxin reductase of S. aureus (designated TrxB), together with its Trx partner 
(TrxA) drew the attention of this study due to their pivotal role in bacterial redox 
homeostasis. The S. aureus thioredoxin system makes an attractive subject of investigation: 
the above-mentioned substrate promiscuity of TrxR proteins has highlighted the importance 
of TrxB and TrxA during oxidative stress in S. aureus. Specifically the ability of S. aureus 
TrxB/TrxA to reduce CoAD or BSSB has not been explored by any previous study. Knowing 
whether these enzymes are capable of reducing these LMW thiol disulfides is especially 
important in the event that the FDRs that are normally responsible for their reduction are 
either inhibited or otherwise inactivated. If TrxB/TrxA could act as the LMW thiol reduction 
system of last resort for S. aureus under such circumstances, it would have important 
implications for the design of any novel antibiotics against this bacterium. 
The importance of any TrxR to bacterial redox balance has naturally led to the investigation 
of potential inhibitors of its activity. Thus far, the most widely-studied inhibitor has been 
ebselen, a lipid-soluble seleno-organic compound that has been found to act as a 
competitive inhibitor of E. coli TrxR (Figure 2.7). The compound does not act as an inhibitor 
of TrxR, but instead competes with oxidised Trx for reduction by TrxR.42 Even more 
importantly; work by Holmgren et al.  indicates that S. aureus is almost 100× more sensitive 
to ebselen than E. coli. This is suggested to be due to the finding that bacteria lacking the 
GSH disulfide-reducing systems, as S. aureus does, are more sensitive to ebselen.15 
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Figure 2.7: The inhibition of the thioredoxin system by ebselen. A) A dimer of ebselen can 
be reduced by the TrxR protein B) Ebselen does not act as a direct inhibitor of TrxR. Rather, 
it competes with the oxidised Trx protein to be reduced by TrxR. Scheme modified from 
Holmgren et al.15 
 
2.3.3.3 Peroxiredoxin reductase (AhpF)  
 
The bacterial peroxiredoxin reductase AhpF is a NADH-dependent peroxiredoxin reductase 
(PrxR) involved in the reduction of H2O2 and organic hydroperoxides.25, 26 It functions in 
tandem with the peroxiredoxin AhpC in a typical two-cysteine reaction, reducing the disulfide 
bridge formed between the redox active Cys residues of AhpC after interaction with 
peroxide. The Prx-PrxR system bears strong resemblance to that of Trx-TrxR, both in 
functional mechanisms and structure. Research on AhpF from Salmonella typhimurium 
suggests that the protein may have evolved from TrxR; a major portion of S. typhimurium 
AhpF displays up to 35% sequence identity to E. coli TrxR and possesses the same flavin-
binding, pyridine nucleotide-binding and redox-active cystine motifs (CxxC).25, 26 
Interestingly, whilst AhpC is ubiquitous across a number of species, AhpF is found strictly in 
eubacteria.  
When the cell is subjected to an oxidative blast, AhpF and AhpC are involved in the direct 
elimination of ROS. Although not involved in the reduction of oxidised cellular proteins, the 
peroxide-reducing system does form part of the redox balancing mechanisms employed by 
S. aureus during oxidative stress. 
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2.3.4 FDRs of unknown function in oxidative stress resistance 
 
Several FDRs have been identified within S. aureus that are projected to function in 
oxidative stress resistance: two DSR subgroup proteins (LipDH and MerA) and one AHR 
subgroup protein (YpdA). Whilst the function of the LipDH protein is well understood, MerA 
and YpdA’s roles in S. aureus redox balance are unclear.   
2.3.4.1 Dihydrolipoamide dehydrogenase (LipDH) 
 
Dihydrolipoamide dehydrogenase (LipDH) is a member of the PNDOR family which forms  
part of the pyruvate dehydrogenase, α-ketoglutarate dehydrogenase and the branched-chain 
α-keto acid dehydrogenase complexes, specifically forming the E3 component.18, 27  
In each complex, the role of LipDH is the same: the enzyme catalyses the re-oxidation of the 
dihydrolipoamide moiety that is covalently bound to the acyl-transferase enzyme (E2) of the 
complex.18, 27 Because of this covalent linkage between LipDH and its substrate (or cofactor), 
it is unlikely that the enzyme will interact with free LMW thiols in the thiol-disulfide 
interchange system. Therefore, although LipDH is strictly also a thiol-disulfide reductase, it is 
not considered to be relevant in the maintenance of redox maintenance through thiol-
disulfide interchange reactions, and was therefore not investigated in this study.  
2.3.4.2 MerA  
 
The merA gene of S. aureus was originally identified as a putative FDR through bioinformatic 
analysis of the bacterial genome. Additionally, a study by Voyich et al. revealed that the 
protein product of the merA gene (a MerA homolog) was heavily involved in the S. aureus 
oxidative stress response.39 This was based on the significant up-regulation (more than 20-
fold) of the gene following phagocytosis by neutrophils, and highlighted the MerA protein as 
a potentially important player in the S. aureus oxidative stress response.39 However, the 
function of this protein and the role that it plays in oxidative stress resistance is not clear, as 
it shows significant homology towards known mercuric ion reductases (see Chapter 3). Such 
a function would not be relevant in the native environment encountered by S. aureus, and 
would not explain its role in eliminating ROS or ROS-inducing damage.   
A comparative analysis of the amino acid sequences of the S. aureus MerA and known 
mercuric reductase enzymes reveals that the former lacks a penultimate Cys-Cys motif 
(Chapter 3). This characteristic is currently deemed to be essential for mercuric ion 
reductase activity, thus suggesting that MerA may fulfil other roles suited to a FDR.11, 19 A 
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basic BLAST analysis of S. aureus MerA further reveals significant sequence identity to 
FDRs such as dihydrolipoamide dehydrogenase and glutathione reductase, which also 
belong to the DSR subgroup.9 The MerA homolog is thus similar in sequence to FDRs that 
do not reduce a corresponding TFP partner, but which rather reduce an oxidized substrate 
(usually a LMW disulfide) directly. It was therefore concluded that MerA may act as a BSSB 
reductase or as an alternate CoAD reductase, the latter activity explaining the apparent non-
essentiality of the CoADR enzyme. 
From the information discussed above, it is clear that the role of MerA in the oxidative stress 
response of S. aureus is both very important, yet still very uncertain. The characterisation of 
this protein may shed much light on the defence mechanisms employed by S. aureus when 
it experiences oxidative stress.   
2.3.4.3 YpdA  
 
The YpdA protein was first identified by Gaballa et al. as a FDR with a potential role in BSH-
dependent processes in B. subtilis.10 Identified by the EMBL STRING programmes, the ypdA 
gene was one of four found to occur with high frequency in the genomes of BSH-
synthesising bacteria. Bioinformatic studies of the S. aureus genome later revealed a YpdA 
homolog, displaying 62% identity to that of the B. subtilis counterpart.13 
Furthermore, YpdA shares strong identity with known thioredoxin reductases, and falls within 
the same AHR subgroup of FDRs as this enzyme.10, 13 Due to the structural similarities 
displayed by YpdA to the above-mentioned enzymes, it is most likely that the FDR requires a 
corresponding TFP (most likely a thioredoxin) in order to carry out its functions. This led to 
the conclusion that YpdA could be responsible for the reduction of oxidized bacilliredoxin 
proteins. However, it has also been proposed as a candidate for the as yet unidentified 
BSSB reductase. Analysis of YpdA’s sequence (by comparison to other FDRs of known 
function) highlights several potential problems with such an analysis (see Chapter 3): first, 
the protein lacks the CxxC active site motif required to perform such functions, strongly 
indicating that it should be inactive as a disulfide reductase (if it follows the standard 
mechanism of these enzymes). Second, the protein was found to possess a sequence insert 
within its NADPH-binding domain, which may potentially affect its ability to bind the pyridine 
nucleotide. Finally, despite many studies echoing the theories postulated by Gaballa et al., 
no BSH-associated activity has been experimentally verified for any YpdA, including the S. 
aureus homolog.   
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2.3.4.4 Summary of the thiol-disulfide interchange mechanisms in S. aureus 
 
 
Figure 2.8: The currently understood thiol redox balancing mechanisms of S. aureus. 
FDRs, TFPs and LMW thiols form the three principal components of the system. Each 
reduces the oxidised version of the other in order to maintain intracellular redox balance. As 
may be seen above many gaps in the current knowledge of the system prevent the picture 
from being completed. 
 
2.4 Unresolved questions in S. aureus redox homeostasis 
 
As can be summarised from the evidence discussed, many gaps remain to be filled in our 
understanding of the redox balancing mechanisms of S. aureus.  Of these, determining the 
native functions of the MerA and YpdA proteins represent the greatest challenge, given that 
their roles in the thiol-disulfide interchange system can thus far only be guessed. The main 
question for both is the same: what role(s) do these two enzymes play in the oxidative stress 
resistance mechanisms of S. aureus? In the case of MerA, is it a functional mercuric ion 
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reductase, despite anomalies in its amino acid sequence? If so, what use could a mercuric 
ion reductase possibly be during oxidative stress? In the case of YpdA, could it be the 
elusive bacillithiol reductase? Does it require a corresponding TFP to function? And if not 
bacillithiol, then which substrate does YpdA act upon?   
TrxB also raises questions, although of a different nature: Is its substrate spectrum wide 
enough that it (together with TrxA) could act as a back-up system for CoADR by acting upon 
CoAD? Or could it act on BSSB as a substrate in a similar manner? What other proteins 
and/or LMW thiol disulfides is it capable of reducing?  
As outlined in Chapter 1, answering these questions forms the basis of this study. Fruitful 
research efforts in this regard will allow for a greater understanding of the varied 
mechanisms employed by S. aureus during oxidative stress. Most importantly, the findings 
drawn from this study may help lay the foundations for the development of novel anti-
staphylococcal agents, of which the world is sorely in need.    
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Chapter 3 
Cloning, expression, purification and characterisation of 
the MerA and YpdA homolog proteins 
 
3.1 Introduction 
 
At the crux of this study lie the questions surrounding the function and activity of MerA and 
YpdA homologs. As functionally uncharacterised FDRs, they represent the greatest 
unknown in the model of S. aureus oxidative stress resistance.  
The MerA homolog is of particular interest based on the significant up-regulation of the merA 
gene following phagocytosis by neutrophils (and therefore presumably after exposure to 
oxidative stress), which suggests that it plays a vital role under these conditions.22 However, 
since MerA shows greatest homology to known mercuric ion reductases, such a conclusion 
would be puzzling since such an activity should have minimal importance in the organism’s 
defense mechanisms against oxidative stress. MerA is therefore likely to play a vital role in 
oxidative stress resistance that may be unrelated to functions associated with its homology 
to mercuric ion reductases. 
The implied link between YpdA and BSH is another important point of interest. Although 
suggested to be a BSSB reductase or bacilliredoxin, the YpdA protein has yet to be 
experimentally verified as such.12 Providing conclusive evidence to such claims would shed 
much light on the role of BSH in S. aureus.  
This chapter will discuss all experimental attempts to assign function to the MerA and YpdA 
proteins of S. aureus, specifically with regards to their potential roles in combatting oxidative 
stress. 
3.2 Results 
3.2.1 Sequence analysis of the MerA homolog by comparison to known mercuric ion 
reductases 
 
The S. aureus MerA homolog is labelled as such based on its sequence similarity with 
flavoproteins that are known to reduce Hg2+ to Hg0, i.e. mercuric ion reductases. These 
proteins have been studied intently for more than 30 years, and are known to possess 
several distinctive sequence characteristics. These include 1) a redox active Cys pair 
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located in the active site, 2) a long N-terminal extension possessing a Cys pair and 3) a 
shorter C-terminal extension possessing a Cys pair. Additionally, like all FDR’s the proteins 
also have one NADPH-binding domain and one FAD-binding domain per subunit 3 (Figure 
3.1). 
The amino acid sequence of MerA was aligned with the sequences of two known mercuric 
ion reductases from different bacterial species to establish the level of its similarity with 
these proteins (Figure 3.2). This alignment reveals several important differences between 
MerA and other known mercuric ion reductases. The most obvious is the drastic difference in 
size between MerA and the other sequences. A large portion of the N-terminal sequence of 
the known mercuric reductases is missing in MerA, including an N-terminal cysteine pair. 
Most critical however, is the lack of the penultimate cysteine pair near the C-terminal. 
Extensive research on the N-terminal domain of mercuric reductase (NmerA) 3, 4, 20 indicated 
that whilst the N-terminal Cys pair is dispensable under normal, non-stressed conditions, 
mutations of the C-terminal Cys pair drastically reduces enzymatic activity.3, 19 More 
specifically it was found that a double Cys→Ala mutant displays no catalytic activity 
whatsoever, while mutation of only one of the Cys residues cause significant decreases in 
kcat and kcat/Km values.3, 19  
These results, taken together with X-ray structure work by Brown et al., suggest that the C-
terminal Cys pair is critically involved with the acquisition of Hg2+ ions in the cell.3, 4 The loss 
or mutation of these residues can thus severely affect enzyme efficiency. The conclusions 
drawn from these studies suggest that a mercuric ion reductase lacking the penultimate Cys 
pair, as MerA does, would be incapable of reducing Hg2+ ions. 
From the sequence analysis of MerA, it is plain to see that the protein lacks several key 
sequence motifs and features, most notably the C-terminal Cys pair. Based on this, it is not 
entirely clear whether the protein is capable of normal mercuric ion reductase activity. In 
spite of this, MerA does contain three other core features of mercuric ion reductases: a core 
active site Cys pair, and both NADPH- and FAD-binding domains. The presence of the 
above features may be sufficient to allow MerA to function, albeit at an impaired rate.   
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Figure 3.1: Schematic representation of the 3D structure of known mercuric ion reductases. 
The black dots indicate cysteine residues. Mercuric ion reductases possess Cys pairs in the 
N- and C-terminals, as well the active site. Scheme adopted from Barkay et al.3 
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Figure 3.2: T-coffee amino acid sequence alignment comparing MerA to known mercuric ion 
reductases from P. aeruginosa and E. coli. The N-terminal and C-terminal Cys pairs are 
marked in blue and purple respectively. The active site Cys pairs are marked in grey, and 
the NADPH-binding domain is outlined in black. The FAD-binding domain stretches between 
residues 100-407.  
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3.2.2 Sequence analysis of YpdA by comparison to known thioredoxin reductases 
 
YpdA has been suggested as the candidate protein for both BSSB reductase and 
bacilliredoxin reductase activity.12 Preliminary sequence analysis indicated that YpdA shows 
the highest similarity to FDRs of the Ahr subgroup12, and its amino acid sequence was 
therefore aligned with that of a well-characterized member of this group, thioredoxin 
reductase (TrxB), as well as a unusual TrxR protein identified in T. acidophilum (TaTrxR) 
(Figure 3.3). The latter was chosen as a protein similar to YpdA, in the sense that it is a 
putative TrxR lacking the known catalytic motifs associated with such a protein. 
Aligning the amino acid sequences of YpdA and TrxB illustrates multiple similarities, but also 
differences between the proteins. The most obvious and important difference is the lack of a 
redox-active Cys pair in YpdA; instead of the typical CxxC motif displayed by both TrxB and 
TaTrxR, it has a FKEA sequence, which seems to bear no functional relevance. The YpdA 
protein does possess two cysteine residues elsewhere in its sequence, although they are not 
located in close proximity with one being found close to the N-terminus, and the other close 
to the C-terminus. As discussed in Chapter 2, the CxxC motif is considered essential to the 
catalytic activity of a TrxR protein, and the anomaly in YpdA should therefore render it 
inactive as a disulfide reductase. This suggests that it either has another unrelated activity, 
or it does not follow the standard mechanism for the reduction of protein and/or LMW 
disulfides. 
Additionally, both YpdA and the TaTrxR display variation in their NADPH binding domains 
compared to that of TrxB. Comparing the TrxB NADPH-binding domain located between 
residues 146 and 219 to those of the other proteins, clearly confirms the previous finding that 
TaTrxR has not maintained the standard NADPH-binding motif: instead of the usual 
VxxxHRRDxxRA sequence, TaTrxR has VxxxEYMPxxMC.13 This drastically influences the 
electrostatics of its binding pocket, and consequently it was found to bind neither NADH nor 
NADPH.  For the corresponding sequence, YpdA has a VxxxYRGGxxSP motif that retains at 
least one Arg residue, while also only introducing small glycine residues. This suggests that 
unlike TaTrxR, YpdA may still bind NADH and/or NADPH, which could lead to the reduction 
of its FAD cofactor.  
3.2.3 Gene amplification and plasmid construction 
 
The merA gene (SAOUHSC_00581) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220. An N-terminal NcoI site and a C-terminal XhoI site were introduced to 
the gene during amplification, thus allowing merA to be cloned into the pET28a(+) 
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expression vector. The restriction sites introduced were chosen such that MerA would be 
expressed with a C-terminal His-tag. The successful formation of a pET28a(+)-merA 
recombinant plasmid was confirmed via digestion screening. 
The ypdA gene (SAOUHSC_01499) was amplified and inserted into the pET28a(+) 
expression vector in a similar manner.  
  
 
Figure 3.3: T-coffee amino acid sequence alignment comparing YpdA to TrxB and a 
putative TrxR from T. acidophilum (TaTrxR). The active site Cys pair of TrxB and 
TaTrxR are marked in purple, whilst the unpaired Cys residues of YpdA are marked 
in blue. The NADPH-binding domain of TrxB is outlined in black. The FAD-binding 
domain stretches from residues 7-283.    
Stellenbosch University  http://scholar.sun.ac.za
 41 
 
3.2.4 Heterologous expression trials 
 
Expression trials were carried out in order to elucidate the optimum expression parameters 
for soluble expression of MerA. The trials were conducted using E. coli BL21* (DE3) cells, 
and expression was allowed to continue overnight. Optimum results were obtained at 22⁰C, 
with a total IPTG concentration of 0.5 mM, as can been seen from the SDS-PAGE analysis 
shown in Figure 3.4.  
Expression trials for YpdA were carried out as described above for MerA. Optimum 
expression was obtained at 37⁰C, with a total IPTG concentration of 0.5 mM, as can be seen 
from the SDS-PAGE analysis shown in Figure 3.5. 
 
Figure 3.4: SDS-PAGE of soluble expressed MerA protein. The crude cell extracts from 
different expression conditions were separated by SDS-PAGE on a 12% gel.The MerA 
protein is tentatively identified based on it having the expected size (as judged by 
comparison to the molecular weight markers) and is indicated by the arrow..  
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Figure 3.5: SDS-PAGE of soluble expressed YpdA protein. The crude cell extracts from 
different expression conditions were separated by SDS-PAGE on a 12% gel. The YpdA 
protein is tentatively identified based on it having the expected size (as judged by 
comparison to the molecular weight markers) and is indicated by the arrow.. 
 
3.2.5 Protein purification 
 
The ideal expression temperatures determined above were used in a large-scale expression 
of MerA. Purification of the protein from bacterial lysate was performed by immobilized metal 
affinity chromatography (IMAC) on an ÄKTAprime system using a 1 mL HiTrap Chelating 
column that was loaded with Ni2+ prior to purification (Figure 3.6) 
The crude lysate containing the His-tagged protein was loaded onto the column and all non-
specific bound proteins were washed off. MerA was eluted by increasing the imidazole 
concentration to 500 mM in the elution buffer (20 mM Tris-HCl, 500 mM NaCl, 500 mM 
imidazole, pH 7.9). The imidazole was removed by buffer exchange using a 5 mL HiTrap 
desalting column and a low salt buffer (25 mM Tris-HCl, 5 mM MgCl2, pH 8.0). Protein 
elution profiles were monitored via UV detection at 254 nm. The protein concentration of 
MerA was determined by a Bradford assay to be 5.65 mg/ml. Additionally, the purified 
protein was bright yellow, indicative of it containing the FAD-cofactor. 
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The large-scale expression of YpdA was carried out using the parameters determined 
through expression trials. Purification of YpdA was conducted in the same manner as that of 
MerA (described above), both through IMAC and gel filtration. The protein concentration of 
YpdA was determined by a Bradford assay to be 3.58mg/ml (Figure 3.6)  
 
Figure 3.6: SDS-PAGE analysis of soluble MerA and YpdA protein after IMAC and gel 
filtration purification. The gel also shows the TrxB and TrxA proteins purified as part of the 
studies described in chapter 4. 
 
3.2.6 Determining the redox cofactor requirements of MerA and YpdA 
 
UV-Vis analysis of the purified MerA and YpdA proteins showed that both gave the 
characteristic spectrum of a flavin cofactor. To determine whether this cofactor can be 
reduced by the binding of NADH and/or NADPH, anaerobic titrations were conducted and 
compared to that of a control, the S. aureus TrxB enzyme. This was done in a manner 
similar to that previously employed to study the cofactor requirement of the TaTrxR 
enzyme.13  
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Figure 3.7: Anaerobic titrations of MerA and YpdA with NADPH and NADH. A) MerA titrated 
with NADPH. B) YpdA titrated with NADPH C) TrxB titrated with NADPH. D) MerA titrated 
with NADH. E) YpdA titrated with NADH F) TrxB titrated with NADH. The proteins were 
titrated via the sequential addition of 0.5 mol NADH/NADPH per 1 mol flavin moiety, until an 
excess of 5 mol NADH/NADPH per 1 mol flavin was reached. 
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The results show that the flavin moiety of MerA was readily reduced in the presence of 
NADPH, with the absorbance at 450 nm decreasing immediately at the addition of 0.5 mol of 
NADPH per 1 mol flavin moeity (Figure 3.7A), which is similar to the response shown by 
TrxB(Figure 3.7C). However, unlike TrxB MerA’s flavin does not seem to be fully reduced 
even after treatment with 5 eq. NADPH. MerA displayed no reaction towards NADH, even at 
molar concentrations in excess of 10-fold (Figure 3.7D), while TrxB did show some reduction 
with NADH, although only when an excess (6 mol eq) were added (Figure 3.7F). This 
confirms that MerA, like TrxB, prefers NADPH as the reductant of its flavin cofactor.  
For YpdA, anaerobic titrations showed that its flavin cofactor was rapidly reduced in the 
presence of NADPH, with the absorbance at 450 nm decreasing noticeably with as little as 
0.5-fold molar excess of NADPH (Figure 3.7B). At 5 eq. NADPH, it was fully reduced. In 
contrast, YpdA displayed no reaction towards NADH, even at molar concentrations in excess 
of 10-fold. This demonstrates that YpdA has the ability to bind redox cofactors (with a similar 
preference as TrxB) in spite of the modifications in its NADPH-binding motif highlighted 
above. 
 
3.2.7. Determination of standard assay conditions 
 
With the knowledge of the respective enzymes’ preferred redox cofactors in hand, we could 
next evaluate their activity towards various substrates. Since neither enzyme has been 
characterized before, we decided to use the same assay conditions used for the only 
characterised non-TFP-requiring FDR in the S. aureus thiol-disulfide redox system, namely 
CoADR. However, this enzyme has been previously been assayed using two different assay 
conditions.17 These conditions are compared in Table 3.1 below. 
To determine which of these conditions gave the best result in our hands, the rate of 
reduction of CoAD by CoADR was monitored spectrophotometrically in 96-well plates by 
following the decrease in NADPH absorbance at 340nm. The assay was conducted using 
both conditions, and the initial reaction rates determined for each. This gave the activity 
profiles shown in Figures 3.8A and 3.8B. 
Both sets of assay data were subsequently fitted to the Michaelis-Menten equation: 
 	= 	
	[]
 	+ 	 []
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Where v0 represents initial velocity of the reaction, Vmax is the maximal reaction velocity and 
KM is the Michaelis constant. In the Michaelis-Menten equation, Vmax occurs at high substrate 
concentrations, whilst KM is equal to the substrate concentration when the reaction velocity is 
half-maximal.  
Catalytic turnover, or kcat, is defined as the maximum number of moles of substrate that may 
be converted to product, per mole of enzyme, in units of time. Catalytic turnover is calculated 
as follows: 
 	= 	
	
[E]
 
Henceforth, all kinetic parameters determined for the various reactions in this study were 
calculated as described above. 
 
Table 3.1: Comparison of published CoADR assay conditions 
Components 
Potassium Phosphate 
Conditions17 
HEPES Conditions23 
Buffer base 50 mM K2HPO4  (pH 7.0) 40 mM HEPES (pH 7.5) 
EDTA 0.5 mM 1.0 mM 
NADPH 32 µM 150 µM 
Enzyme 20 nM 20 nM 
Initiator (substrate) 600µM CoAD 600µM CoAD 
Temperature 25⁰C 37⁰C 
Duration 2mins 10mins 
Wavelength 340nm 340nm 
 
The results are summarized in Table 3.2. Although both assays generated very similar 
kinetic data, the potassium phosphate conditions were ultimately selected for use as a 
standard assay to determine the activity of MerA and YpdA, primarily based on it showing 
lower errors overall and on the higher consistency in the raw data obtained.  
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Figure 3.8: A comparison of the steady-state kinetics of the two CoADR assay conditions. 
A) Potassium phosphate conditions. Under these conditions, the data obtained displayed 
fewer standard errors and proved more reproducible. B) HEPES conditions. Despite yielding 
a very similar profile, the data obtained under the HEPES conditions displayed greater 
errors. All experiments were performed in triplicate.  
 
. Table 3.2: Comparison of the kinetic parameters of the two CoADR assays 
 KM (µM) Vmax (nmols.s-1) kcat (s-1) 
Potassium Phosphate 2.36 ± 0.32 0.011 ± 0.0003 2.75 
HEPES 2.63 ± 1.46 0.008 ± 0.0009 2 
 
B 
A 
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3.2.8 Catalytic activity of MerA 
 
The characterisation of MerA was designed to explore two main ideas: 
1. The protein was hypothesised to act as a secondary LMW thiol disulfide reductase 
during oxidative stress, in which case it may be able to reduce CoAD, and/or BSSB. 
2. The homology of MerA to that of known mercuric reductases required that it be 
tested for potential mercuric ion reductase activity, even if this activity cannot be 
relevant in the context of redox balance maintenance. If the protein was found to 
reduce mercuric ions, then a working theory had to be developed as to the use of this 
function towards redox balance. 
The following assays were therefore conducted to provide evidence in support or against 
these ideas. 
3.2.8.1 MerA activity towards common LMW thiol disulfides 
 
MerA was initially tested with the disulfides of known LMW thiols of S. aureus to determine 
its ability to reduce these. Using the phosphate buffer conditions described above, MerA was 
tested with CoAD and BSSB, as well as the CoA precursor, pantethine. The enzyme CoADR 
was assayed with CoAD under identical conditions, acting as a positive control to indicate 
the reduction of a disulfide (Figure 3.9). The results showed that MerA has no disulfide 
reductase activity with any of the substrates tested. 
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Figure 3.9: Catalytic activity of MerA towards various disulfides as monitored at 340nm. 
MerA was unable to reduce the disulfides CoAD, BSSB or pantethine. CoADR was assayed 
with CoAD under the same conditions, acting as a positive control for disulfide reductase 
activity. 
 
3.2.8.2 MerA activity as a mercuric ion reductase 
 
The routine mercuric reductase activity assay, described by Walsh et al., was used to 
confirm whether or not the MerA homolog was a functional mercuric ion reductase.7 Known 
mercuric ion reductase enzymes catalyse the reduction of Hg2+ in a NADPH-dependent 
manner. Thus the reaction progress may be followed spectrophotometrically by monitoring 
the decrease in absorbance of NADPH at 340 nm. The MerA homolog of S. aureus was 
found to reduce Hg2+ in the form of HgCl2, giving the activity profile shown in Figure 3.10. 
Using this data and the Michaelis-Menten equation, the parameters in Table 3.3 were 
determined. In comparison to the Km values determined for known mercuric ion reductases, 
the Km for MerA and HgCl2 is much higher. This suggests that Hg2+ may not be the real 
substrate for MerA.  
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Figure 3.10: Steady-state kinetic profile of MerA with HgCl2. 
 
 
Table 3.3: Comparison of the kinetic parameters of MerA with that of known mercuric ion 
reductases. 
Mercuric reductases with 
HgCl2 
KM (µM) Vmax (nmols.s-1) kcat (s-1) 
MerA 169 ± 50.5 0.727 ± 0.093  0.74 
Mercuric reductase 
P. aeruginosa 7 
12  - - 
Mercuric reductase 
E. coli W224 7 
20  - - 
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3.2.8.3 MerA as a potential ferric ion reductase 
 
MerA’s ability to reduce Hg2+, albeit poorly, suggested that it had a latent activity towards the 
reduction of metals. In the context of the bacterial cell’s redox chemistry, the most important 
metal is iron, as oxidative damage will convert all the Fe2+ found as enzyme cofactors (or 
part of enzyme cofactors, such as the iron sulphur clusters) to Fe3+.1 MerA was therefore 
assayed with nitrilotriacetic acid-Fe(III) (FeNTA) in order to assess the protein’s ability to 
reduce Fe3+ (Figure 3.11). FeNTA was prepared according to the protocol laid out by 
Bunescu et al.6 MerA was assayed with FeNTA using the same protocol as described for the 
MerA-HgCl2 assay 3.  
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Figure 3.11: Steady-state kinetic profile of MerA with FeNTA.  
 
Using this kinetic profile, kinetic parameters were determined (Table 3.4). These show that 
MerA has a far greater affinity for Fe3+ (in FeNTA) than for Hg2+ (in HgCl2), indicating that the 
former is a more likely substrate for the protein. Moreover, the KM observed for MerA with 
Fe3+ is comparable with that of characterised ferric ion reductases, although it has a much 
lower kcat compared to these enzymes. This is a further indication that Fe3+ may the 
preferred substrate of MerA. Conversely, MerA’s Vmax for the FeNTA reaction is much lower 
than that observed of HgCl2. Thus, while MerA has a much higher affinity for Fe3+ as a 
substrate, the reaction will proceed at a much lower rate at saturating conditions. 
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Table 3.4: Comparison of the kinetic parameters of MerA and known ferric reductases acting 
upon Fe3+. 
Protein 
Organism 
KM (µM) Vmax (nmols.s-1) kcat (s-1) 
MerA 
S. aureus 
7.66 ± 4.52 0.127 ± 0.017 0.732 
FerA 
P. denitirifcans 21 
5.5 ± 0.7 - 14 ± 1 
FerA 
R. sphaeroides 21 
4.2 ± 0.2 - - 
 
3.2.9 Catalytic activity of YpdA 
 
The characterisation of YpdA’s putative activity centred around three main concepts:  
1. YpdA has been linked to BSH-related functions, and therefore its activity towards 
BSSB needed to be assessed. At the same time YpdA’s activity towards other S. 
aureus biothiols could also be explored in order to rule out potential substrate 
promiscuity. 
2. YpdA has also been linked to bacilliredoxin (a TFP) activity in the thiol-disulfide 
interchange system. Since no bacilliredoxin has been characterized in S. aureus as 
yet (two putative bacilliredoxins, YphP and YtxJ, have been proposed to act in 
Bacillus subtilis), YpdA’s activity with a generic TFP such as TrxA could be tested.  
 
3.2.9.1 Catalytic activity of YpdA towards common LMW thiol disulfides 
 
YpdA was initially tested with the known LMW thiols of S. aureus to determine its ability to 
reduce one or more of these. Under the standard conditions determined previously, YpdA 
was tested with CoAD and BSSB, as well as the CoA precursor, pantethine. The enzyme 
CoADR was assayed with CoAD under identical conditions, acting as a positive control. 
Referring to Figure 3.12, the reaction of CoADR with CoAD shows a rapid decrease in the 
NADPH concentration, clearly indicating that the disulfide substrate is being reduced in a 
NADPH-dependent manner. Conversely, YpdA demonstrates no measurable reduction of 
the disulfide substrates, as the NADPH content remains constant throughout the assay. 
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Figure 3.12: Catalytic activity of YpdA towards various disulfides as monitored at 340nm. 
YpdA was unable to reduce the disulfides CoAD, BSSB or pantethine. CoADR was assayed 
with CoAD under the same conditions, acting as a positive control for disulfide reductase 
activity. 
 
3.2.9.2 YpdA as putative thioredoxin reductase  
 
The sequence similarities between YpdA and known TrxR proteins suggest that it may 
require a corresponding TFP protein in order to function. Putative bacilliredoxins have been 
identified (for example YphP and YtxJ, see Chapter 2), and are suggested to fill this role.2 
However, since these proteins were not available in our lab, a more generic alternative was 
employed to test YpdA’s potential to act as a TrxR protein. YpdA was thus assayed for 
enzymatic activity using TrxA as an interacting partner, and with DTNB as a substrate.  
DTNB, or Ellman’s reagent, is commonly used in assays to test thioredoxin activity, as a 
functional TrxR and Trx pair can reduce the compound’s disulfide bond. The reduction of this 
bond leads to the formation of 2-nitro-5-thiobenzoate (NTB2-), a bright yellow compound, the 
formation of which may be monitored at 412 nm.11 
The reduction of DTNB via the thioredoxin system proteins, TrxB and TrxA, was used as a 
positive control for the experiment (Figure 3.13). The reaction of TrxB and TrxA with DTNB 
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shows the clear increase of NTB2- concentration over the duration of the assay. In contrast, 
negative controls, whereby either TrxA or TrxB have been eliminated from the reaction, 
show no quantifiable NTB2- formation. Assaying YpdA with TrxA demonstrated no 
discernible NTB2- formation. This indicates that the proteins did not interact in a manner 
similar to that of known thioredoxin system proteins. This could be the result of one of two 
situations: Either YpdA is not capable of acting on TrxA as a substrate (it is not its cognate 
TFP partner), or YpdA is not a functional TrxR at all. 
 
 
Figure 3.13: Interaction between YpdA and TrxA, using DTNB as a substrate. YpdA was 
assayed with DTNB as a substrate. TrxA was supplied as an interacting TFP partner. The 
same assay was conducted with TrxB and TrxA as a positive control. Negative controls were 
as follows: TrxA-YpdA assay, omitting TrxA; TrxA-YpdA assay, omitting YpdA; TrxB-TrxA 
assay, omitting TrxA; TrxB-TrxA assay, omitting TrxB. 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
0 0.5 1 1.5 2 2.5
Ab
so
rb
an
ce
 
at
 
41
2n
m
Time (min)
TrxA & TrxB
TrxB only
TrxA & YpdA
YpdA only
TrxA only-TrxA &
YpdA
TrxA only-TrxA &
TrxB
Stellenbosch University  http://scholar.sun.ac.za
 55 
 
3.3 Discussion 
3.3.1 Activity characterization of MerA 
 
Known mercuric ion reductases require NADPH for enzymatic activity and do not utilise 
NADH.3, 4 The titration of MerA with NADPH and NADH mirrors the reduction reactions 
expected from both functional mercuric ion reductases and most disulfide oxidoreductases. 
While this result does not confirm MerA as either a mercuric ion or LMW thiol-disulfide 
reductase, it did clearly establish the cofactor requirements of the protein, and could be 
utilised for further experimentation.  
A BLAST search using the MerA amino acid sequence as query reveals a high sequence 
similarity between MerA and known glutathione reductases. This in itself is not surprising, 
since both the mercuric ion and glutathione reductase enzymes are flavoproteins belonging 
to the DSR subgroup of FDRs.8 Additionally, a study by Walsh et al.7, 8 found that the two 
enzymes also share extensive homology with regards to their active site sequences, as well 
as their mechanism of action towards substrates. Therefore, the initial hypothesis that MerA 
could be involved with the reduction of LMW disulfides in S. aureus was prompted by the 
similarities between MerA and glutathione reductase. However, MerA was not found to be 
able to reduce any of the disulfides in the assay conditions that were used. The results 
obtained from these assays thus indicate that MerA does not act as a LMW disulfide 
reductase.  
The results from the bioinformatic analysis initially made it seem unlikely that MerA could as 
a functional mercuric ion reductase, based on the lack of a pair of Cys residues at its C-
terminal. Thus it was surprising to observe the quantifiable reduction of Hg2+ by MerA. The 
calculated Km value for MerA with HgCl2 was compared to that of three other bacterial 
mercuric reductases (Table 3.3). This revealed that MerA had a much lower affinity for HgCl2 
than that of the known mercuric reductases.3 This lowered substrate affinity in MerA may be 
due to its lack of the C-terminal cysteine pair, as these Cys residues are suggested to assist 
the protein in acquiring Hg2+ from its environment.3, 4 
The successful demonstration of mercuric ion reductase activity in MerA made the protein’s 
role in oxidative stress resistance even more puzzling. Although undeniably important to a 
cell experiencing heavy metal stress, the link between Hg2+ reduction and oxidative stress 
resistance was unclear. This led to the formation of a new hypothesis: was the protein 
capable of reducing another biologically-relevant metal, namely iron? Iron-derived ions such 
as Fe2+ are critical in cellular function, as they often act as enzyme cofactors essential to 
catalysis, e.g. heme, iron-sulfur clusters, etc.16  The results of the assay were clear: MerA 
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was found to not only reduce Fe3+ in the form of an NTA complex, but displayed a higher 
affinity for the ion compared to Hg2+. Whether or not the protein’s ability to reduce Fe3+ is 
relevant to the organism’s oxidative stress defense mechanisms requires further 
investigation, especially since the NTA counter-ion is not biologically relevant. However, this 
study has proposed a tentative hypothesis for the Fe3+-reducing abilities of MerA during 
oxidative stress, namely the reactivation of oxidised 4[Fe-S] enzymes.   
4[Fe-S] proteins are heavily involved in a number of crucial cellular processes, most notably 
electron transport.9 The inactivation of these proteins for whatever reason would thus have 
disastrous implications for a living cell. During an oxidative blast, O2•- can react with the 
4[Fe-S] clusters of proteins possessing such groups, creating inactive Fe (IV) enzymes and 
often leading to the release of Fe3+ ions from the enzyme.5,9,24 However, these proteins may 
be re-activated in the presence of free Fe2+ ions and thiols.24 At this point, MerA could 
potentially assist in the reactivation of the oxidised 4[Fe-S] by reducing Fe3+ to Fe2+. The 
inactivated proteins could thus be restored to normal function. Furthermore, whilst S. aureus 
possesses membrane-bound ferric ion transporters for iron assimilation, it does not have 
native cytoplasmic ferric reductases.21 This leaves a niche in the S. aureus proteomic 
network for a ferric reductase during oxidative stress. The exploration of this hypothesis as a 
function of MerA may thus be investigated in future studies.    
3.3.2 Activity characterization of YpdA 
 
Gaballa et al. were the first to draw attention to YpdA, identifying it as a FDR with a potential 
role in BSH-dependent processes in B. subtilis.12 Flagged by the EMBL STRING 
programmes, the ypdA gene was one of four found to occur with high frequency in the 
genomes of BSH-synthesising bacteria. Bioinformatic studies of the S. aureus genome later 
revealed that YpdA bears high sequence homology to known TrxR proteins, and falls within 
the same FDR subgroup: the alkyl hydroperoxide reductases12 
The similarities displayed by YpdA to TrxR suggest that it is likely to require a corresponding 
TFP (most likely a thioredoxin) in order to carry out its functions. This led to the conclusion 
that YpdA could be responsible for the reduction of oxidized bacilliredoxin proteins. 
Moreover, it has also been proposed as a candidate for the as yet unidentified BSSB 
reductase. 
The sequence analysis of YpdA revealed several deviations from that of known TrxR 
proteins. Most glaringly was the lack of an active-site Cys pair in a CxxC motif. This motif is 
highly conserved amongst TrxR proteins, as it is critical to catalytic function.11 Additionally, 
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the NADPH-binding site of YpdA contains a sequence insert, as well as several changes in 
amino acid residues. Although this potentially indicated that the protein would not be able to 
bind NADPH, this was disproven; anaerobic titrations of YpdA with NADPH demonstrated 
effective binding and reduction of the protein.  
A study by Hernandez et al. attempting to characterise a putative TrxR prompted 
reconsideration regarding the cofactor requirements of YpdA. 13 Hernandez found that the 
putative TrxR utilised neither NADPH nor NADH as cofactor, relying instead on an unknown 
electron donor.13 It was thus deemed prudent to determine the preferred cofactor of YpdA, if 
any, prior to commencing assays. 
Under standard conditions, YpdA exhibited no activity with any of the disulfides supplied, 
including BSSB. This result was not unexpected; if YpdA is in fact a TrxR-like protein, then it 
would be incapable of reducing disulfide bonds in the absence of an interacting TFP partner. 
This result did, however, rule YpdA out as a direct BSSB reductase.  
Research into the BSH-related pathways has identified two putative bacilliredoxins: YphP 
and YtxJ (see Chapter 2). These proteins have been suggested as potential interacting 
partners for YpdA, and as such must be tested with the latter in order to ascertain such a 
hypothesis. However, neither protein was cloned and purified as part of this study, although 
this clearly needs to form part of future work. Thus, in the absence of these putative 
partners, YpdA was assayed with TrxA as a substitute. The inability of YpdA to reduce 
DTNB in the presence of TrxA thus leads to two different conclusions. First, YpdA could be 
incapable of reducing DTNB with any TFP partner other than its own. Alternatively, YpdA 
simply is not a functional TrxR. When revisiting the bioinformatic analysis of YpdA, the 
protein’s lack of a redox-active cysteine pair does suggest that it may not be capable of 
catalysing the reduction of any disulfide. However, a final conclusion regarding YpdA cannot 
be drawn without an attempt to identify any interacting protein partners. Such studies will 
thus undoubtedly form part of a future investigation into the protein’s function.   
3.4 Conclusion 
3.4.1 MerA 
 
The MerA protein was originally deemed incapable of mercuric ion reductase activity due to 
its missing penultimate Cys-pair and other sequence variations from the known. Despite 
these anomalies, MerA was proven capable of reducing Hg2+ ions in a NADPH-dependant 
manner. The protein demonstrated a much lower affinity for HgCl2 compared to that of 
characterised mercuric ion reductases, averaging a KM of 169 µM compared to their reported 
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KM values of12-20 µM. 7 This is potentially attributed to the missing C-terminal Cys-pair, 
which is implicated in the acquisition of Hg2+ for catalysis. 
The reduction of Fe3+ by MerA was shown to yield a significantly lower Km in the presence of 
Fe3+ compared to Hg2+, indicating that the former is a more likely substrate for the protein. 
The results of this study therefore proposes that MerA may reduce Fe3+ during oxidative 
stress, thus providing Fe2+ for the reactivation of oxidised 4[Fe-S] cluster proteins. 
3.4.2 YpdA 
 
Despite much sequence identity with a functional TrxR protein, YpdA lacks the critical active 
site CxxC motif for disulfide reductase function. Furthermore, the bioinformatic analysis 
revealed an insert and various amino acid residue discrepancies in the NADPH-binding 
domain of YpdA. This does not appear to affect the protein’s ability to bind NADPH however, 
as anaerobic titrations of YpdA with NADPH revealed rapid and effective reduction of the 
FAD cofactor. 
Under standard conditions, YpdA was incapable of reducing CoAD, BSSB or pantethine. 
Initially, this was attributed to lack of a corresponding TFP, as known TrxR proteins require 
an interacting TFP for catalytic function. TrxA was thus provided as a TFP for YpdA in order 
to test the latter’s ability to interact with a generic Trx protein. Assaying YpdA with TrxA and 
DTNB revealed no quantifiable activity. This could be the result of two possible situations: 
Either YpdA requires its specific TFP for activity and is unable to interact with TrxA, or YpdA 
is an inactive TrxR homolog possessing no disulfide reductase activity. A thorough protein-
protein interaction study with YpdA will be required by future studies in order to establish 
whether or not YpdA is in fact capable of enzymatic activity.  
3.5 Experimental 
3.5.1 Materials 
 
All buffer components and other chemicals were obtained from Sigma-Aldrich. BSSB was 
generously provided by Dr. Chris Hamilton of the University of East Anglia. CoAD was 
synthesised by Bertus Moolman at the University of Stellenbosch. Restriction enzymes were 
purchased from Fermentas. All primers used were synthesised by Inqaba Biotec in Pretoria.  
3.5.2 DNA amplification 
3.5.2.1 merA 
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The merA gene (SAOUHSC_00581) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220 (isolated using a genomic DNA extraction kit from Novagen) using the 
following primers: Forward: 5’-GCAGTCACTGTCACCATGG TCGTAATATTG -3’ and 
reverse: 3’-CACCAGGTTTTTATGTTTCTCGAGGAAATTAAATAA -5’. With these primers an 
NcoI (underlined) and an XhoI (underlined) restriction enzyme site are introduced in the 
forward primer and the reverse primer respectively.  The amplification mixture was set up as 
follows: Tubes 1 to 3 contained Pfu buffer, 0.4 mM dNTP mix, 1 mM forward primer, 1 mM 
reverse primer, 1 ng genomic DNA, 1.25 U Pfu DNA polymerase and distilled, deionized 
water (ddH2O) to a final volume of 25 µl. Tubes 4 to 6 contained all of the above 
components, with only the substitution of ddH2O for a 1.7 M solution of betaine 
monohydrate, bringing the final concentration of betaine monohydrate to 1 M in each 
mixture. The PCR program had an initial step of 2 min at 94°C followed by 30 cycles of 
denaturation at 94°C for 15 s, annealing at 55°C for 30 s and polymerization for 1 min at 
70°C. The reaction mixtures were subjected to gel electrophoresis on a 1% agarose gel and 
subsequently visualized through gel staining with SYBR™ gold (Invitrogen) and viewed on a 
Darkreader. The best product bands were seen at an MgSO4 concentration of 3 mM and 4 
mM. The product bands were excised and purified using the Novagen gel clean-up kit. 
These PCR products were used in the construction of the pET28a-merA plasmids.   
3.5.2.2 ypdA 
 
The ypdA gene (SAOUHSC_01499) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220 using the following primers: Forward: 5’-GAGGCCGAACATAT 
GCAAAAAGTTGAAAGT-3 and reverse: 5’-GTACATAGACCTCTCGAGTTATGATTCTAAG 
GG-3’. With these primers an NdeI (underlined) and an XhoI (underlined) restriction enzyme 
site are introduced in the forward primer and the reverse primer respectively. Amplification of 
the ypdA gene was performed according to the procedure previously discussed. Following 
amplification, the reaction mixtures were visualised and the product band purified as 
previously outlined. Optimum results were obtained at an MgSO4 concentration of 4 mM. 
3.5.3 Restriction digests 
 
Restriction digests were carried out on the merA PCR product and pET28a(+) using NcoI 
and XhoI restriction enzymes (Fermentas). The pET28a(+) plasmids were isolated from E. 
coli using the Zippy® plasmid preparation kit (Fermentas). The digestions were performed 
using Fermentas FastDigest buffer, 16 µL PCR product/plasmid and 10 U each NcoI and 
XhoI. These reactions were incubated at 37°C for 1 hour prior to 1% agarose gel 
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electrophoresis. Bands of the correct size were excised and purified using the Novagen gel 
clean-up system. Restriction digests of the ypdA PCR product and pET28a(+) were carried 
out using NdeI and XhoI (Fermentas) in the same procedure as described above. 
3.5.4 Plasmid construction  
 
The pET28a(+) plasmid system was used for the construction of all expression vectors 
required for this study. The molar concentrations of both the gene inserts and isolated 
plasmids were obtained using the Qubit® Fluorometric Quantitation system (Life 
Technologies). Equal molar amounts of the restriction digested plasmid and PCR product 
were added together in a volume of 5 µL. A final volume of 10.5 µL was obtained by adding 
Quick Ligation Buffer and 10 U of Quick T4 DNA Ligase (both purchased from New England 
Biolabs) to the reaction mixture. Following incubation for 5 minutes at room temperature, the 
mixture was transformed into competent E. coli Mach1 cells. Transformation was performed 
as follows: 1 µL of the plasmid-insert construct was added to 80 µL of chemically-competent 
Mach 1 cells, and incubated on ice for 30 mins. The cell mixture was heat-shocked at 42⁰C 
for 45 seconds, and then cooled on ice for 5 mins. The cell mix was then incubated at 37⁰C 
for 1 hour before being centrifuged at 8000 RPM for 4 mins. Half of the supernatant was 
discarded, with the cell pellet being re-suspended in the remaining supernatant.  The re-
suspended cells were then plated onto LB plates containing 30 mg/L kanamycin and 
incubated overnight at 37°C. 
Colonies were screened for the merA and ypdA gene inserts by lysis in gel loading buffer 
and direct electrophoresis on a pre-stained 1% agarose gel, using the parent pET28a(+) 
plasmid as a reference. Only plasmids that appeared larger than the pET28a(+) were 
selected for further screening. The corresponding colonies of the chosen plasmids were 
cultured overnight in LB media containing 30 mg/L kanamycin at 37°C. Plasmids from these 
cultures were purified using the Zyppy Plasmid Miniprep I Kit (Zymo Research) and 
subjected to a restriction digest reaction with the appropriate restriction enzymes. The 
restriction digestion reactions were subsequently visualised on a pre-stained 1% agarose gel 
to determine the correct banding patterns. The plasmid was sequenced and, if construction 
was successful, the plasmid was stocked for future use. 
3.5.5 Protein expression and purification 
 
Protein expression for all targets was first conducted in small scale in order to determine 
optimum conditions for soluble expression of the proteins of interest. Following elucidation of 
these conditions, large scale expression of target proteins was performed. All growth media 
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and plates used in the expression of the target proteins contained the antibiotic kanamycin 
(30 mg/L).  
3.5.5.1 Expression trials 
 
An expression plasmid was selected from those constructed earlier and transformed into E. 
coli BL21*(DE3) cells. An overnight culture was grown from a single colony of the 
transformed cells in preparation for expression trials. All expression trials were conducted in 
15 mL Corning® centrifuge tubes. Each tube contained 4 mL LB media and 100 µL 
overnight culture, forming an expression culture. Expression cultures were incubated at 
37°C with shaking until an OD600 reading of 0.6 was reached, at which point IPTG was 
added from a 10 mM stock. Following the addition of IPTG, the cultures were topped up with 
LB media to give a final volume of 5 mL. The following parameters were varied in order to 
determine the optimum environment for soluble protein expression: 
• The final IPTG concentration in each tube: 1 mM, 0.5 mM, 0.2 mM and 0.05 mM. 
• The temperature at which expression took place: 22°C or 37°C. 
Following overnight expression, the cells were harvested via centrifugation and either 
processed immediately or stored at -20°C for use at a later opportunity. 
3.5.5.2 Large scale expression 
 
LB media (500 mL) was inoculated with 2 mL of an overnight culture of E. coli BL21*(DE3) 
containing the desired expression plasmid. The culture was incubated on an orbital shaker at 
37°C until an OD600 of 0.5-0.6 was reached. The optimum amount of IPTG (pre-determined 
from small scale trials) was added and the culture was further incubated at the similarly 
determined temperature overnight. Cells were then collected by centrifugation at 4500×g for 
30 minutes at 4°C. As with small scale expressions, the pellets obtained were either 
processed directly after collection or stored at -20°C until required. 
3.5.5.3 Analysis of expression trials 
 
Cell pellets obtained from small scale expression trials were re-suspended in 300 µL 
BugBuster® protein extraction solution (Novagen) and incubated on a shaking platform for 
20 minutes at room temperature. The reaction mixture was centrifuged at 1300×g for 20 
minutes, with the supernatant subsequently transferred to a clean tube. The cell debris pellet 
was re-suspended in 100 µL of 10 mM Tris-HCl, pH 8.0. 15 µL of both the supernatant and 
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re-suspended cell pellets were analysed on a 12% SDS-PAGE gel for soluble and insoluble 
proteins respectively.  
3.5.5.4 Purification of large scale protein expression 
 
The cell pellets obtained from large scale expression were re-suspended in binding buffer 
(20 mM Tris-HCl, 5 mM imidazole, 500 mM NaCl, pH 7.0), in a volume equating to 10 mL 
per 1 g of pellet. Cells were lysed via sonication, and the cell debris removed by 
centrifugation at 1500×g for 30 minutes at 4⁰C. The supernatant was filtered with a Pall 
Acrodisc PSF GxF/GHP 0.45 µm filter prior to injection into the ÄKTAprime system 
(Amersham Biosciences). 
All proteins were purified using a 1 mL HiTrap Chelating HP column. Prior to loading the 
protein, the column was equilibrated with 10 column volumes of H2O and 5 column volumes 
of binding buffer (20 mM Tris-HCl, 5 mM imidazole, 500 mM NaCl, pH 7). The protein was 
loaded and followed by two wash steps: 10 column volumes of binding buffer, followed by 
another 5 column volumes containing 15% elution buffer (20 mM Tris-HCl, 500 mM NaCl, 
500 mM imidazole, pH 7.9). This second wash step was essential for eliminating any non-
specifically bound proteins. The recombinant MerA-His protein was eluted over the course of 
10 column volumes of 100% elution buffer. For the duration of the purification, the flow rate 
was maintained at 1 mL/min, whilst protein elution profiles were monitored at 254 nm. All 
columns used were purchased from Amersham Biosciences. 
3.5.5.5 SDS-PAGE gel analysis 
 
Proteins obtained from both small and large scale expression were visualised by SDS-PAGE 
using 12% gels. An equal volume of 2× SDS-PAGE loading buffer (0.125 M Tris-HCl, 4% 
SDS, 30% glycerol, 1.5% β-mercaptoethanol and bromophenol blue, pH 6.8) was added to 
the protein samples and the reaction mixtures were incubated at 95⁰C for 5 minutes. 15 µL 
of all samples were loaded onto the gel and electrophoresed in SDS-PAGE running buffer 
(0.1% SDS, 0.025 M Tris and 0.192 M glycine). Completed gels were stained with 
Coomassie blue stain (45 mL MeOH, 40 mL ddH2O, 10 mL acetic acid and 250 mg 
Coomassie Brilliant Blue) for 30 minutes and later de-stained for 2 hours using destain 
solution (45 mL MeOH, 40 mL ddH2O, 10 mL acetic acid). 
3.5.5.6 Protein concentration determination 
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All protein concentration was determined using the Bradford protein assay. A standard curve 
of absorbance versus concentration was plotted with the use of BSA standards (Biorad). All 
protein samples and standards were treated with Coomassie Brilliant Blue and incubated at 
room temperature for 5-10 minutes. Absorbance was subsequently measured at 595 nm 
using a Thermo Varioskan multiplate spectrometer in 96-well plates. 
3.5.6 Enzymology 
 
Unless otherwise stated, all assays performed were done in triplicate. 
3.5.6.1 Anaerobic titration with NADPH/NADH 13 
 
YpdA was titrated with NADPH (0.5 – 5.0 mol NADPH per mol FAD) under anaerobic 
conditions at 25⁰C in 50 mM Tris-HCl (pH 7.5), and 150 mM NaCl. The titration was 
conducted in an anaerobic cuvette, sealed with a gas-tight rubber septum and repeatedly 
flushed with nitrogen gas. All reactants were flushed with nitrogen gas prior to titration. The 
reduction of the enzyme flavin by NADPH was monitored by collecting spectra from 800 nm 
to 240 nm. The anaerobic titration of TrxB with NADPH and NADH was used as a control. 
This process was then repeated with YpdA and NADH, as well as MerA with NADPH and 
NADH. 
3.5.6.2 Standard assay conditions: Potassium phosphate conditions17 
 
A master mix was made up containing 50 mM potassium phosphate (pH 7.0), 0.5 mM EDTA, 
35.56 µM NADPH and 22.22 nM of the CoADR enzyme. Substrate solutions of CoAD were 
prepared separately. The concentrations varied such that the final CoAD concentrations fell 
between 0 – 60 µM. All solutions were incubated for 5 min at 25 °C before the assay. The 
reaction was initiated by adding 180 µL of the master mix to 20 µL of the substrate sample 
within a 96-well plate, creating a final volume of 200 µL. The decrease in absorbance at 340 
nm was followed for 2 min at 25⁰C in a Thermo Varioskan multiplate spectrometer. 
3.5.6.3 Standard assay conditions: HEPES conditions17 
 
A master mix was prepared containing 40 mM HEPES (pH 7.5), 1.0 mM EDTA, 166.67 µM 
NADPH and 22 nM CoADR enzyme. Substrate solutions of CoAD were prepared separately. 
The concentrations varied such that the final CoAD concentrations fell between 0 – 60 µM. 
All solutions were incubated for 5 min at 37 °C before the assay. The reaction was initiated 
by adding 225 µL of the master mix to 25 µL of the substrate sample within a 96-well plate, 
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creating a final volume of 250 µL. The decrease in absorbance at 340 nm for each enzyme 
was followed for 10 min at 37⁰C in a Thermo Varioskan multiplate spectrometer. 
3.5.6.4 Protein activity tests under standard conditions17 
 
The ability of MerA and YpdA to reduce CoAD was assayed at 25 °C in a total volume of 180 
µL. The reaction mixture contained 50 mM potassium phosphate (pH 7.0), 0.5 mM EDTA 
and 32 µM NADPH. The final CoAD concentration was 60 µM.  One unit of activity is defined 
as the amount of enzyme catalysing the oxidation of 1 µmol of NADPH (decrease in A340) 
per minute at 25 °C.   
A master mix was made up containing 50 mM potassium phosphate (pH 7.0), 0.5 mM EDTA, 
35.56 µM NADPH and 22.22 nM of the particular enzyme being tested. A substrate solution 
of 600 µM CoAD was prepared separately, and all solutions were incubated for 5 min at 25 
°C before the assay. The reaction was initiated by adding 180 µL of the master mix to 20 µL 
of the substrate sample, mixed briefly, and 180 µL of the reaction mixture transferred to a 1 
cm pathlength cuvette. The decrease in absorbance at 340 nm was followed for 1 min at 
25⁰C in an Agilent Cary 60 UV-Vis spectrometer. This procedure was repeated with the 
substrates BSSB and pantethine. 
3.5.6.5 Mercuric reductase activity assay 7 
 
The mercuric reductase activity of MerA was assayed at 37⁰C in a total volume of 180 µL 
containing 80 mM sodium phosphate (pH 7.4), 200 µM NADPH, 100 µM HgCl2 and 1 mM 2-
mercaptoethanol. 3 
A master mix was prepared consisting of 88.89 mM sodium phosphate (pH 7.4), 222.22 µM 
NADPH, 111.11 µM HgCl2 and 1.11 mM 2-mercaptoethanol. Both the master mix and a 
separate substrate solution of undiluted MerA protein were incubated at 37⁰C for 10 minutes 
prior to initiation. The reaction was initiated by adding 180 µL of the master mix to 20 µL of 
the MerA protein, mixing briefly and finally transferring 180 µL of the reaction mix to a 1 cm 
pathlength cuvette. The decrease in absorbance at 340 nm was followed for 2 min at 25⁰C in 
an Agilent Cary 60 UV-Vis spectrometer. 
3.5.6.6 MerA Fe(III) reduction assay 6 ,7, 14 
 
The activity of MerA towards Fe3+ was assayed at 37⁰C in a total volume of 180 µL 
containing 80 mM sodium phosphate (pH 7.4), 200 µM NADPH, 100 µM Fe(III)-NTA and 1 
mM 2-mercaptoethanol. 
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Fe(III)-NTA was prepared as follows2: To a 100 mL aqueous solution containing 4 mM NTA 
at a pH 4.0 was added, under stirring, 100 mL of a freshly prepared solution of 4 mM 
Fe(ClO4)3. This mixture was stirred for 1 h, and the pH was adjusted to 4.0 with 1 M NaOH. 
The total complexation of the iron was controlled by UV-visible spectrophotometry (ɛ260 = 
6,000 M−1 cm−1). The pH of the FeNTA solution was adjusted to 7.0 with 1 M NaOH just 
before the experiment. 
A master mix was prepared consisting of 88.89 mM sodium phosphate (pH 7.4), 222.22 µM 
NADPH, 111.11 µM FeNTA and 1.11 mM 2-mercaptoethanol. Both the master mix and a 
separate substrate solution of undiluted MerA protein were incubated at 37⁰C for 10 minutes 
prior to initiation. The reaction was initiated by adding 180 µL of the master mix to 20 µL of 
the MerA protein, mixing briefly and finally transferring 180 µL of the reaction mix to a 1 cm 
pathlength cuvette. The decrease in absorbance at 340 nm was followed for 2 min at 25⁰C in 
an Agilent Cary 60 UV-Vis spectrometer. 
3.5.6.7 YpdA-TrxA assay 13 
 
YpdA was assayed with DTNB using TrxA as an interacting protein partner. A master mix 
was prepared consisting of 58.82 µM TrxA, 17.6 nM YpdA and 225 µM NADPH. A substrate 
solution of 1 mM DTNB was prepared. All reagents were incubated at 37⁰C for 10 min prior 
to the assay. The reaction was initiated by adding 160 µL of master mix to 40 µLDTNB. The 
increase in absorbance at 412 nm was followed for 2 min at 37⁰C in a Thermo Varioskan 
multiplate spectrometer. 
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Chapter 4 
Cloning, expression, purification and activity analyses of 
the S. aureus TrxB and TrxA proteins 
 
4.1 Introduction 
 
Thioredoxin (Trx) and thioredoxin reductase (TrxR) are important disulfide reductases in 
most living cells. Collectively known as the thioredoxin system, Trx, TrxR and NADPH are 
capable of reducing a number of protein disulfide substrates, most notably peroxiredoxins, 
ribonucleotide reductases and methionine sulfoxide reductases.10 The importance of the 
thioredoxin system is further highlighted by the fact that TrxR proteins are essential to 
bacterial cells; any attempts to create trxR-null mutants prove lethal to cell survival.4, 11 
The apparent non-essentiality of CoADR for S. aureus survival indicates that a second 
system exists that may reduce CoAD with comparable efficiency.4 The results of Chapter 3 
have already indicated that neither MerA nor YpdA are likely to fulfil such a role. Thus the 
thioredoxin system, which is already a known and flexible disulfide-reducing system, would 
be the logical option for such a back-up. This study thus aims to explore the S. aureus 
thioredoxin system’s activity towards LMW thiol disulfides in order to assess their role in 
oxidative stress.   
This chapter describes the cloning, expression and purification of the S. aureus Trx and 
TrxR proteins (TrxA and TrxB respectively), as well as their activity towards LMW thiol 
disulfides.     
4.2 Results 
4.2.1 Gene amplification and plasmid construction 
 
The trxB gene (SAOUHSC_00785) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220. An N-terminal NdeI site and a C-terminal XhoI site were introduced to 
the gene during amplification, thus allowing trxB to be cloned into the pET28a(+) expression 
vector. The restriction sites introduced were chosen such that TrxB would be expressed with 
an N-terminal His-tag. The formation of a pET28a(+)-trxB hybrid plasmid was confirmed with 
digestion screening and sequencing of the constructed plasmid and insert.. 
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The trxA gene (SAOUHSC_01100) was similarly inserted into the pET28a(+) expression 
vector to create the pET28a(+)-trxA hybrid plasmid. 
4.2.2 Heterologous expression trials 
 
Expression trials were carried out in order to elucidate the optimum expression parameters 
for soluble expression of TrxB. The trials were conducted using E. coli BL21* (DE3) cells and 
expression was allowed to continue overnight. Optimum expression was obtained at 37⁰C, 
with a total IPTG concentration of 0.5 mM, as can been seen from the SDS-PAGE analysis 
shown in Figure 4.1.   
 
Figure 4.1: SDS-PAGE analysis of soluble expressed TrxB protein. The crude cell extracts 
from different expression conditions were separated by SDS-PAGE on a 12% gel. The TrxB 
protein is tentatively identified based on it having the expected size (as judged by 
comparison to the molecular weight markers) and is indicated by the arrow. 
 
Expression trials for TrxA were carried out using the same protocol as described above for 
TrxB. Optimum expression was obtained at 22⁰C, with an IPTG concentration of 0.5 mM, as 
demonstrated by the SDS-PAGE analysis shown in Figure 4.2.   
Stellenbosch University  http://scholar.sun.ac.za
 70 
 
 
 
Figure 4.2: SDS-PAGE of soluble expressed TrxA protein. The crude cell extracts from 
different expression conditions were separated by SDS-PAGE on a 12% gel. The TrxA 
protein is tentatively identified based on it having the expected size (as judged by 
comparison to the molecular weight markers) and is indicated by the arrow. 
 
4.2.3 Protein purification 
 
The large-scale expression of TrxB was carried out using the optimum expression 
parameters determined through the above-mentioned expression trials. Purification of the 
protein from bacterial lysate was performed by immobilized metal affinity chromatography 
(IMAC) on an ÄKTAprime system using a 1 mL HiTrap Chelating column that was loaded 
with Ni2+ prior to purification.  
The His-tagged protein was loaded onto the column and all non-specific bound proteins 
were washed off. MerA was eluted using a buffer containing an increased concentration of 
imidazole (20 mM Tris-HCl, 500 mM NaCl, 500 mM imidazole, pH 7.9). The imidazole was 
removed by buffer exchange using a 5 mL HiTrap desalting column and a gel filtration buffer 
(25 mM Tris-HCl, 5 mM MgCl2, pH 8.0). The protein elution profile was monitored via UV 
detection at 254 nm. The concentration of TrxB was determined by a Bradford assay to be 
2.77 mg/ml.  
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The large-scale expression of TrxA was carried out using the parameters determined 
through expression trials (detailed above). The purification of TrxA was conducted according 
to the same protocol described for TrxB, using both IMAC and gel filtration to obtain a pure 
protein sample. The concentration of TrxA was determined by a Bradford assay to be 2.43 
mg/ml. 
 
Figure 4.3: SDS-PAGE analysis of soluble TrxB and TrxA protein after IMAC and gel 
filtration purification. The gel also shows the MerA and YpdA proteins discussed in Chapter 
3. 
 
4.2.4 TrxB/TrxA activity assays 
4.2.4.1 Confirming TrxB activity and determining its kinetic parameters 
 
Typically, the activity of a TrxR and Trx pair is established in an assay employing insulin as 
the substrate.2, 9  However, pure laboratory-grade bovine insulin could not be obtained for 
this study due to import constraints, and thus the alternative DTNB-based assay was used to 
establish TrxB/TrxA activity.  
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Working in concert, a functional TrxR and Trx are capable of reducing 5,5’-dithiobis(2-
nitrobenzoic) acid (DTNB) to 5-thio-2-nitrobenzoic acid (NTB2-) in a NADPH-dependent 
reaction.7 This reaction is routinely used in activity assays of TrxR-Trx protein pairs. 
TrxB and TrxA were demonstrated to be active by observing the NADPH-dependent 
reduction of DTNB. The kinetic parameters of the reaction were individually determined for 
TrxA and NADPH, as shown in Figures 4.3A and 4.3B respectively. The assay data was 
fitted to the Michaelis-Menten equation and kinetic parameters for the reaction were 
determined as described in Chapter 3. The TrxA protein was compared with Trx1 of B. 
subtilis, each as reaction substrates for S. aureus TrxB and B. subtilis TR respectively (Table 
4.1). TrxA demonstrates comparable affinity towards its TrxR partner, TrxB, as that of Trx1 
towards TR.   
4.2.4.2 Activity analyses of TrxB and TrxA with CoAD 
 
To determine if TrxB and TrxA are reactive towards CoAD, the enzyme’s activity was 
assayed by substituting DTNB for CoAD as a substrate. Reactions could therefore not be 
followed based on substrate reduction; instead, the reaction progress was observed 
spectrophotometrically in a 1 cm pathlength cuvette by monitoring the decrease in NADPH 
concentration at 340 nm. The resulting activity profile is shown in Figure 4.4. The thioredoxin 
system’s activity towards CoAD was compared to that of CoADR in order to ascertain the 
system’s affinity and efficiency towards CoAD (Table 4.2). The thioredoxin system displays a 
far lower affinity for CoAD than that of CoADR, with a Km more than 20-fold higher than 
CoADR. Similarly, the CoADR-CoAD reaction demonstrates a significantly faster maximal 
reaction rate and higher turnover over number versus those of the thioredoxin system. 
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Figure 4.3: Activity of TrxA and TrxB with DTNB. A) The concentrations of TrxB, NADPH 
and DTNB were kept fixed at 15 nM, 200 µM and 1 mM respectively; whilst the TrxA 
concentration was varied between 0-100 µM. B) The concentration of NADPH was varied 
between 0-200 µM, whilst TrxA, TrxB and DTNB were fixed at 50 µM, 15 nM and 1 mM 
respectively. 
 
 
A 
B 
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Table 4.1: Comparison of the kinetic parameters of the S. aureus thioredoxin system with 
that of B. subtilis. 
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Figure 4.4: Activity of the thioredoxin system towards CoAD. CoAD concentration was 
varied between 0-150 µM. 
 
Table 4.2: The kinetic parameters of the thioredoxin system and CoADR with CoAD 
Substrate 
Enzyme(s) KM (µM) Vmax (nmols.s
-1) kcat (s-1) 
CoAD 
TrxB & TrxA 
53.0 ± 22.7 0.105  ± 0.02 0.327 
CoAD 
CoADR 2.36 ± 0.32 0.011 ± 0.00 2.75 
 
Substrate KM (µM) Vmax (nmols.s-1) kcat (s-1) 
TrxA 13.9 ± 3.00 0.221  ± 0.015 73.6 
NADPH 83.1 ± 26.2 0.057  ± 0.008 19.1 
Trx1  
B. subtilis thioredoxin 
system 7 
8.41 ± 0.32 - 13.5 ± 0.15 
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4.2.4.3. Activity analyses of TrxB and TrxA with pantethine 
 
Following the poor results of the thioredoxin system with CoAD, pantethine was selected for 
testing. The compound, which is a CoA precursor and breakdown product, is both smaller 
and less negatively charged than CoA. These features may play a role in the thioredoxin 
system’s ability to reduce a particular disulfide substrate, and pantethine was thus assayed 
in order to test this. TrxB and TrxA were assayed with pantethine under the conditions used 
for the activity test with DTNB. 
The reaction progress was observed spectrophotometrically in a 1cm pathlength cuvette by 
monitoring the NADPH decrease at 340nm. Kinetic parameters were determined for the 
reaction according to the procedure detailed in Chapter 3, with the Michaelis-Menten plot 
shown in Figure 4.5. The kinetic parameters for the thioredoxin system-pantethine reaction 
are shown in Table 4.3, as well as compared to those of the other LMW thiol disulfide 
substrates in Table 4.5. The results show that the thioredoxin system does not reduce CoAD 
as well as CoADR, but that this poorer reaction is not due to the charge or size of CoAD. 
 
Figure 4.5: Activity of the thioredoxin system towards pantethine. The pantethine 
concentration was varied between 0-1000 µM. 
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Table 4.3: The kinetic parameters of the thioredoxin system towards the LMW thiol disulfide, 
pantethine 
Substrate KM (µM) Vmax (nmols.s-1) kcat (s-1) 
Pantethine 650 ± 209 0.089  ± 0.015 0.277 
 
4.2.4.4 Activity analyses of TrxB and TrxA with BSSB 
 
The results of Chapter 3 rule MerA and YpdA out for displaying any direct activity towards 
BSSB. Thus, the potential activity of the thioredoxin system towards this particular LMW 
disulfide was investigated.  
TrxB and TrxA were assayed with BSSB under the conditions used for the activity test with 
DTNB; reaction progress was observed by monitoring the NADPH decrease at 340nm. The 
kinetic parameters for the reaction were determined as described in Chapter 3, with the 
Michaelis-Menten plot shown below (Figure 4.6). The calculated kinetic parameters are 
compared to those of the B. subtilis thioredoxin system in Table 4.4, as well as the other 
LMW disulfide substrates in Table 4.5.  
The S. aureus thioredoxin system shows very similar affinity towards BSSB as that of B. 
subtilis, but has a turnover number that is nearly 20-fold higher.  
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Figure 4.6: Activity of the thioredoxin system towards BSSB. BSSB concentration was 
varied between 0-1000 µM. The kinetic parameters obtained for the S. aureus thioredoxin 
system with BSSB are compared to that of the M. tuberculosis system, as described by the 
Hamilton group.‡ 
 
 
Table 4.4: The kinetic parameters of the thioredoxin system towards the LMW thiol disulfide, 
BSSB. 
Substrate 
Enzyme 
KM (µM) Vmax (nmols.s-1) kcat (s-1) 
BSSB 
S. aureus TrxB/TrxA 275 ± 80.8 0.199 ± 0.021 0.621 
BSSB 
M. tuberculosis TrxB/TrxC‡ 
291 ± 64 - 0.0314 
 
‡Unpublished results, CJ. Hamilton et al. (University of East Anglia) (Personal 
communication). 
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4.2.4.5 Comparison of the TrxB/TrxA kinetic parameters with different substrates 
 
The kinetic parameters of the thioredoxin system with the three different disulfides that were 
tested are compared in Table 4.5. Of the three substrates assayed, CoAD appears to be the 
favoured substrate. The TrxA protein displays the highest affinity for CoAD, with a KM 5-fold 
and12-fold lower than that of BSSB and pantethine respectively. Additionally, the catalytic 
efficiency calculated for CoAD is the highest of the three substrates, providing a basis for S. 
aureus’s ability to survive even in the absence of a functional CoADR enzyme.  
 
Table 4.5: A comparison of the kinetic parameters of the thioredoxin system with different 
disulfide substrates. 
Substrate KM (µM) Vmax (nmoles.s-1) kcat (s-1) kcat/Km (s-1.mM-1) 
CoAD 53.0 ± 22.7 0.105 ± 0.02 0.327 6.17 
BSSB 275 ± 80.8 0.199 ± 0.021 0.621 2.25 
Pantethine 650 ± 209 0.088  ± 0.015 0.276 0.426 
 
4.3 Discussion 
 
A 1992 study by Aharonowitz et al. identified a putative thioredoxin system in Streptomyces 
clavuligerus that showed disulfide reductase activity towards CoAD.1 Aside from this study, a 
review of the current literature on bacterial thioredoxin systems indicates that any activity 
between the system and CoAD remains untested. As CoA appears to be the predominant 
LMW thiol active in maintaining S. aureus redox balance, the non-essentiality of the CoADR 
protein indicates that a secondary system must exist to fulfil this activity if needed.4 Verifying 
the existence of such a system and its activity was thus essential.  
The effective and reproducible reduction of CoAD by the S. aureus thioredoxin system 
indicates that the compound is a viable substrate for the system. TrxB and TrxA thus appear 
capable of acting as an effective back-up system to CoADR, reducing CoAD during oxidative 
stress and/or under conditions when CoADR is not fully functional. 
TrxB/TrxA’s activity toward pantethine, the disulfide of pantetheine, was also tested. 
Pantetheine is a breakdown product of CoA, and also serves as the precursor to CoA 
salvage biosynthesis.5 Pantethine may also be broken down in the cell to form pantothenic 
acid and cysteamine, after which the former is phosphorylated as part of the first step in the 
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synthesis of CoA.5 Pantethine was tested as a substrate of TrxB /TrxA based on its 
importance as an alternative CoA precursor and breakdown product, and also to ascertain 
whether the system shows great activity to one of CoA’s moieties which is uncharged. 
However, the thioredoxin system enzymes did not display high affinity towards pantethine 
however, and the overall catalytic efficiency of the reaction was low compared to that of 
CoAD. 
Although numerous proteins have been reported to be involved in BSH-related pathways,6, 8, 
a dedicated BSSB-reductase protein or system has yet to be experimentally verified. The 
results presented in Chapter 3 demonstrated that neither MerA nor YpdA had any BSSB 
reductase activity. A study of the B. subtilis thioredoxin system by the Hamilton lab at the 
University of East Anglia demonstrated that it is capable of reducing BSSB effectively. 
Therefore the S, aureus TrxB/TrxA system’s ability to reduce BSSB was tested, and found to 
reduce BSSB equally well, with comparable kinetic parameters to those reported by 
Hamilton et al. for the B. subtilis proteins. Consequently, the thioredoxin system remains the 
only protein system with demonstrable BSSB-reducing activity in BSH-containing bacteria.    
4.4 Conclusion 
 
The thioredoxin system of S. aureus is a versatile system capable of reducing multiple 
disulfide substrates, including LMW disulfides. In this study was demonstrated that TrxB/ 
TrxA is capable of reducing the disulfides of both CoA and BSH, the LMW thiols of S. aureus 
known to play a role in the maintenance of redox balance and xenobiotic detoxification. 
Additionally, the thioredoxin system is able to reduce the compound pantethine which is 
directly involved in the metabolism of CoA. Therefore, the thioredoxin system of S. aureus 
exhibits much substrate promiscuity, which allows it to play a critical role in the maintenance 
of S. aureus redox balance beyond its usual roles associated with the reduction of essential 
proteins. These findings provide additional support for TrxB as a viable target for the 
development of novel antibiotics. 
4.5 Experimental 
4.5.1 Materials 
 
All buffer components were purchased from Sigma-Aldrich. BSSB was generously provided 
by the Hamilton group of the University of East Anglia. CoAD was synthesised by Bertus 
Moolman at the University of Stellenbosch. Restriction enzymes were purchased from 
Fermentas. All primers used were synthesised by Inqaba Biotec in Pretoria.  
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4.5.2 DNA amplification 
4.5.2.1 trxB 
 
The trxB gene (SAOUHSC_00785) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220 (isolated using the DNA extraction kit from Novagen) using the following 
primers: Forward: 5’-GGAGGCGTTAATCATATG ACTGAAATAGAT-3’ and reverse: 5’-
TCTTAATTCGACCTCGAGTTAAGCTTGATCGTT-3’. With these primers an NdeI 
(underlined) and an XhoI (underlined) restriction enzyme site is introduced in the forward 
primer and the reverse primer respectively. Amplification of the trxB gene was performed as 
follows: Tubes 1 to 3 contained Pfu buffer, 0.4 mM dNTP mix, 1 mM forward primer, 1 mM 
reverse primer, 1 ng genomic DNA, 1.25 U Pfu DNA polymerase and distilled, deionized 
water (ddH2O) to a final volume of 25 µL. The PCR program had an initial step of 2 min at 
94°C followed by 30 cycles of denaturation at 94°C for 15 s, annealing at 55°C for 30 s and 
polymerization for 1 min at 70°C. Following amplification, the reaction mixtures were 
visualised and the product band purified as previously outlined. Excellent results were 
obtained at MgSO4 concentrations of both 3 mM and 4mM. 
4.5.2.2 trxA 
 
The trxA gene (SAOUHSC_01100) was amplified from genomic Staphylococcus aureus 
DNA strain RN4220 using the following primers: Forward: 5’-GGATTGGCACATATG 
GCAATCGTAAAA-3’ and reverse: 5’-GTCGTCATTGGTCTCGAGTTATAAATGTTTATC-3’. 
With these primers an NdeI (underlined) and an XhoI (underlined) restriction enzyme site is 
introduced in the forward primer and the reverse primer respectively. Amplification of the 
trxA gene was performed according to the same procedure described for trxB. Following 
amplification, the reaction mixtures were visualised and the product band purified as 
previously outlined. Excellent results were obtained at MgSO4 concentrations of both 3mM 
and 4 mM. 
4.5.3 Restriction digests 
 
Restriction digests were carried out on both the trxB and trxA PCR products, as well as 
pET28a(+), using NdeI and XhoI restriction enzymes (Fermentas). The pET28a(+) plasmids 
were isolated from E. coli using the Zippy® plasmid preparation kit (Fermentas). The 
digestions were performed using Fermentas FastDigest buffer, 16 µL PCR product/plasmid 
and 10U each NcoI and XhoI. These reactions were incubated at 37°C for 1 hour prior to 1% 
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agarose gel electrophoresis. Bands of the correct size were excised and purified using the 
Novagen gel clean-up system.  
4.5.4 Plasmid construction  
 
The pET28a(+) plasmid system was used for the construction of all expression vectors 
required for this study. The molar concentrations of both the gene inserts and isolated 
plasmids were obtained using the Qubit® Fluorometric Quantitation system (Life 
Technologies).  Equal molar amounts of the restriction digested plasmid and PCR product 
were added together in a volume of 5 µlL. A final volume of 10.5 µL was obtained by adding 
Quick Ligation Buffer and 10 U of Quick T4 DNA Ligase (both purchased from New England 
Biolabs) to the reaction mixture. Following incubation for 5 minutes at room temperature, the 
mixture was transformed into competent E. coli Mach1 cells. Transformation was performed 
as follows: 1 µL of the plasmid-insert construct was added to 80 µL of chemically-competent 
Mach 1 cells, and incubated on ice for 30 mins. The cell mixture was heat-shocked at 42⁰C 
for 45 seconds, and then cooled on ice for 5 mins. The cell mix was then incubated at 37⁰C 
for 1 hour before being centrifuged at 8000 RPM for 4 mins. Half of the supernatant was 
discarded, with the cell pellet being re-suspended in the remaining supernatant. The re-
suspended cells were then plated onto LB plates containing 30 mg/L kanamycin and 
incubated overnight at 37°C. 
Colonies were screened for the trxA and trxB gene inserts via electrophoresis on a pre-
stained 1% agarose gel, using the parent pET28a(+) plasmid as a reference. Only plasmids 
that appeared larger than the pET28a(+) were selected for further screening. The 
corresponding colonies of the chosen plasmids were cultured overnight in 30 mg/L 
kanamycin LB media at 37°C. Plasmids from these cultures were purified using the Zyppy 
Plasmid Miniprep I Kit (Zymo Research) and subjected to a restriction digest reaction with 
the appropriate restriction enzymes. The restriction digestion reactions were subsequently 
visualised on a pre-stained 1% agarose gel and, if the correct band pattern was observed, 
the successfully constructed plasmids were stocked for future use. 
4.5.5 Protein expression and purification 
 
Protein expression for all targets was first conducted in small scale in order to determine 
optimum conditions for soluble expression of the proteins of interest. Following determination 
of these conditions, large scale expression of target proteins was performed. All growth 
media and plates used in the expression of the target proteins contained the necessary 
concentrations of the antibiotic kanamycin (30 mg/L).  
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4.5.5.1 Expression trials 
 
An expression plasmid was selected from those constructed earlier and transformed into E. 
coli BL21*(DE3) cells. An overnight culture was grown from a single colony of the 
transformed cells in preparation for expression trials. All expression trials were conducted in 
15 mL Corning® centrifuge tubes. Each tube contained 4 mL LB media and 100 µL 
overnight culture, forming an expression culture. Expression cultures were incubated at 
37°C with shaking until an OD600 reading of 0.6 was reached, at which point IPTG was 
added from a 10 mM stock. Following the addition of IPTG, the cultures were topped up with 
LB media to give a final volume of 5 mL. The following parameters were varied in order to 
determine the optimum environment for soluble protein expression: 
• The final IPTG concentration in each tube: 1mM, 0.5 mM, 0.2 mM and 0.05 mM. 
• The temperature at which expression took place: 22°C or 37°C. 
Following overnight expression, the cells were harvested via centrifugation and either 
processed immediately or stored at -20°C for use at a later opportunity. 
4.5.5.2 Large scale expression 
 
LB media (500 mL) was inoculated with 2 mL of an overnight culture of E. coli BL21*(DE3) 
containing the desired expression plasmid. The culture was incubated on an orbital shaker at 
37°C until an OD600 of 0.5-0.6 was reached. The optimum amount of IPTG (pre-determined 
from small scale trials) was added and the culture was further incubated at the similarly 
determined temperature overnight. Cells were then collected through centrifugation at 
4500×g for 30 minutes at 4°C. As with small scale expression, the pellets obtained were 
either processed directly after collection or stored at -20°C until required. 
4.5.5.3 Analysis of expression trials 
 
Cell pellets obtained from small scale expression trials were re-suspended in 300 µL 
BugBuster® protein extraction solution (Novagen) and incubated on a shaking platform for 
20 minutes at room temperature. The reaction mixture was centrifuged at 1300×g for 20 
minutes, with the supernatant subsequently transferred to a clean tube. The cell debris pellet 
was re-suspended in 100 µL of 10 mM Tris-HCl, pH 8.0. 15 µL of both the supernatant and 
re-suspended cell pellets were analysed on a 12% SDS-PAGE gel for soluble and insoluble 
proteins respectively. 
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4.5.5.4 Purification of large scale protein expression 
 
The cell pellets obtained from large scale expression were re-suspended in binding buffer 
(20 mM Tris-HCl, 5 mM imidazole, 500 mM NaCl, pH 7.0), in a volume equating to 10 mL 
per 1 g of pellet. Cells were lysed via sonication, and the cell debris removed by 
centrifugation at 1500×g for 30 minutes at 4⁰C. The supernatant was filtered with a Pall 
Acrodisc PSF GxF/GHP 0.45 µm filter prior to injection into the ÄKTAprime system 
(Amersham Biosciences). 
All proteins were purified using a 1 ml HiTrap Chelating HP column. Prior to loading the 
protein, the column was equilibrated with 10 column volumes of H2O and 5 column volumes 
of binding buffer (20 mM Tris-HCl, 5 mM imidazole, 500 mM NaCl, pH 7). The protein was 
loaded and followed by two wash steps: 10 column volumes of binding buffer, followed by 
another 5 column volumes containing 15% elution buffer (20 mM Tris-HCl, 500 mM NaCl, 
500 mM imidazole, pH 7.9). This second wash step was essential for eliminating any non-
specifically bound proteins. The recombinant TrxB-His and TrxA-His proteins were eluted 
over the course of 10 column volumes of 100% elution buffer. For the duration of the 
purification, the flow rate was maintained at 1ml/min, whilst protein elution profiles were 
monitored at 254 nm. All columns used were purchased from Amersham Biosciences. 
4.5.5.5 SDS-PAGE gel analysis 
 
Proteins obtained from both small and large scale expression were visualised by SDS-PAGE 
using 12% gels. An equal volume of 2× SDS-PAGE loading buffer (0.125 M Tris-HCl, 4% 
SDS, 30% glycerol, 1.5% β-mercaptoethanol and bromophenol blue, pH 6.8) was added to 
the protein samples and the reaction mixtures were incubated at 95⁰C for 5 minutes. 15 µL 
of the samples were loaded onto the gel and electrophoresed in SDS-PAGE running buffer 
(0.1% SDS, 0.025 M Tris and 0.192 M glycine). Completed gels were stained with 
Coomassie blue stain (45 mL MeOH, 40 mL ddH2O, 10 mL acetic acid and 250 mg 
Coomassie Brilliant Blue) for 30 minutes and later de-stained for 2 hours using destain 
solution (45 mL MeOH, 40 mL ddH2O, 10 mL acetic acid). 
4.5.5.6 Protein concentration determination 
 
All protein concentration was determined using the Bradford protein assay in 96-well plates. 
A standard curve of absorbance versus concentration was plotted with the use of BSA 
standards (Biorad). All protein samples and standards were treated with Coomassie Brilliant 
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Blue and incubated at room temperature for 5-10 minutes. Absorbance was subsequently 
measured at 595 nm using a Thermo Varioskan multiplate spectrometer. 
4.5.6 Enzymology 
 
Unless otherwise stated, all assays performed were done in triplicate. 
4.5.6.1 TrxB and TrxA activity assay: Trx Km 
 
The assay conditions were adapted from protocols set out by Aharonowitz at al and 
Gustafsson et al.2, 7 A master mix was prepared containing 0.26 M HEPES (pH 7.6), 0.01 M 
EDTA, 2.0 mM NADPH and 15nM TrxB, whilst TrxA concentrations were varied between 2-
100 µM. Solutions of 1 mM DTNB were  prepared, and all reagents were incubated at 37⁰C 
for 10 min prior to commencing. The reaction was initiated by adding 160 µL of master mix 
to 40 µL DTNB in a 96-well plate. The increase in absorbance at 412 nm was followed for 2 
min at 37⁰C in a Thermo Varioskan multiplate spectrometer. All assays were performed in 
triplicate. 
4.5.6.2 TrxB and TrxA activity assay: NADPH Km 
 
Assay adapted from protocols set out by Aharonowitz at al and Gustafsson et al.2, 7 A master 
mix was prepared containing 0.26 M HEPES (pH 7.6), 0.01 M EDTA, 2.0 mM, 15nM TrxB 
and 50 µM TrxA. NADPH concentrations were varied between 2-200 µM. Substrate 
solutions of 1 mM DTNB were  prepared, and all reagents were incubated at 37⁰C for 10 min 
prior to commencing. The reaction was initiated by adding 160 µL of master mix to 40 µL 
DTNB in a 96-well plate. The increase in absorbance at 412 nm was followed for 2 min at 
37⁰C in a Thermo Varioskan multiplate spectrometer. All assays were performed in triplicate. 
4.5.6.3 CoAD assay 
 
Assay adapted from protocols set out by Aharonowitz at al. 2 A pre-mix was prepared 
containing 0.26 M HEPES (pH 7.6), 0.01 M EDTA and 2.0 mM NADPH. The master mix was 
prepared by adding 40 µl of pre-mix to 40 µl of undiluted TrxB protein and 20 µl of undiluted 
TrxA enzyme. Substrate solutions of CoAD were prepared, with the concentrations varied 
between 0-100 µM. Both the master mix and substrate mixes were incubated at 37⁰C prior 
to the assay. The reaction was initiated through the addition of 100 µl of master mix to 20 µl 
of substrate, mixed briefly, and 120 µL of the reaction mixture transferred to a 1 cm 
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pathlength cuvette. The decrease in absorbance at 340 nm was followed for 2 min at 37⁰C in 
an Agilent Cary 60 UV-Vis spectrometer. All assays were performed in triplicate. 
 
The above procedure was repeated for the assays with BSSB and pantethine as substrates. 
For both the BSSB and pantethine assays, the substrate concentrations were varied from 0-
1000 µM.  
 
4.6 References 
 
1. Aharonowitz, Y.; Av-Gay, Y.; Schreiber, R.; Cohen, G., Characterization of a 
broad-range disulfide reductase from Streptomyces clavuligerus and its possible 
role in beta-lactam antibiotic biosynthesis. Journal of Bacteriology 1993, 175 (3), 
623-629. 
2. Aharonowitz, Y.; Borovok, I.; Cohen, G.; Uziel, O.; Katz, L., Recombinant 
Staphylococcus thioredoxin reductase, and inhibitors thereof useful as 
antimicrobial agents. WO Patent 1,999,045,123: 1999. 
3. Arnér, E. S.; Holmgren, A., Physiological functions of thioredoxin and thioredoxin 
reductase. European Journal of Biochemistry 2000, 267 (20), 6102-6109. 
4. Chaudhuri, R. R.; Allen, A. G.; Owen, P. J.; Shalom, G.; Stone, K.; Harrison, M.; 
Burgis, T. A.; Lockyer, M.; Garcia-Lara, J.; Foster, S. J., Comprehensive 
identification of essential Staphylococcus aureus genes using Transposon-
Mediated Differential Hybridisation (TMDH). BMC Genomics 2009, 10 (1), 291. 
5. Duprè, S.; Graziani, M. T.; Rosei, M. A.; Fabi, A.; Grosso, E., The enzymatic 
breakdown of pantethine to pantothenic acid and cystamine. European Journal of 
Biochemistry 1970, 16 (3), 571-578. 
6. Gaballa, A.; Newton, G. L.; Antelmann, H.; Parsonage, D.; Upton, H.; Rawat, M.; 
Claiborne, A.; Fahey, R. C.; Helmann, J. D., Biosynthesis and functions of 
bacillithiol, a major low-molecular-weight thiol in Bacilli. Proceedings of the 
National Academy of Sciences 2010, 107 (14), 6482-6486. 
7. Gustafsson, T. N.; Sahlin, M.; Lu, J.; Sjöberg, B.-M.; Holmgren, A., Bacillus 
anthracis thioredoxin systems, characterization and role as electron donors for 
ribonucleotide reductase. Journal of Biological Chemistry 2012, 287 (47), 39686-
39697. 
8. Helmann, J. D., Bacillithiol, a new player in bacterial redox homeostasis. 
Antioxidants & Redox Signaling 2011, 15 (1), 123-133. 
Stellenbosch University  http://scholar.sun.ac.za
 86 
 
9. Holmgren, A., Thioredoxin catalyzes the reduction of insulin disulfides by 
dithiothreitol and dihydrolipoamide. Journal of Biological Chemistry 1979, 254 
(19), 9627-9632. 
10. Kalinina, E.; Chernov, N.; Saprin, A., Involvement of thio-, peroxi-, and 
glutaredoxins in cellular redox-dependent processes. Biochemistry (Moscow) 
2008, 73 (13), 1493-1510. 
11. Uziel, O.; Borovok, I.; Schreiber, R.; Cohen, G.; Aharonowitz, Y., Transcriptional 
regulation of the Staphylococcus aureus thioredoxin and thioredoxin reductase 
genes in response to oxygen and disulfide stress. Journal of Bacteriology 2004, 
186 (2), 326-334. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 87 
 
Chapter 5 
Conclusions and future work 
 
5.1 Summary of results achieved 
 
This study set out to functionally characterize four proteins implicated in maintaining the 
redox balance of S. aureus. Two FDRs, MerA and YpdA, were shown to not participate in 
the direct reduction of LMW thiol disulfides. MerA instead demonstrated the ability to reduce 
two biologically-relevant transition metal ions without the aid of an interacting protein partner: 
Hg2+ and Fe3+. Fe3+ was further shown to be favoured over Hg2+ as a substrate of MerA, 
which has implications for the protein’s role in oxidative stress resistance.  
YpdA was shown to be incapable of reducing any of the LMW thiol disulfides found in S. 
aureus, even in the presence of a generic TFP protein, TrxA. This suggests that YpdA may 
be unable to perform catalytic functions in the absence of its cognate interacting partner. 
Alternatively, the protein may perform a different cellular function unrelated to LMW disulfide 
reduction or oxidative stress resistance.    
The thioredoxin system proteins of S. aureus, TrxB and TrxA, demonstrated measurable 
reduction of the three LMW thiol disulfides assayed. However, the kinetic parameters 
determined for the reactions suggest that the thioredoxin proteins do not display great affinity 
for these substrates. Therefore, these proteins may be more likely to reduce LMW thiol 
disulfides under critical conditions, as opposed to acting as the primary reducing system for 
these compounds. 
5.2 Assigning oxidative stress-related functions to MerA and YpdA 
 
In Chapter 3, the attempts at assigning substrates and catalytic function to MerA and YpdA 
are detailed. Sequence comparison of the MerA protein to that of known mercuric 
reductases revealed two missing components: both the N- and C-terminal Cys-pairs. MerA 
was however shown to possess more fundamental features, such as the core, catalytic site 
Cys pair, and intact NADPH- and FAD-binding domains.    
Demonstrating LMW thiol disulfide reductase activity in MerA was unsuccessful, as the 
protein proved incapable of reducing CoAD, BSSB or pantethine. Thereafter, MerA was 
tested for its ability to function as a mercuric reductase. Although successful, the protein 
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showed a greatly decreased affinity for HgCl2 compared to that of known mercuric ion 
reductases.2 This has been attributed to MerA’s lack of C-terminal Cys-pair, a feature which 
has been suggested to be involved in Hg2+ acquisition.1 Subsequent tests with MerA and 
Fe3+ revealed that the protein was capable of reducing the metal ion. Moreover, MerA 
displayed affinity for Fe3+ comparable to that of known ferric ion reductases from other 
bacterial species.6  
These results indicate that MerA preferentially reduces Fe3+ as a substrate. Since the protein 
has been strongly implicated in oxidative stress resistance functions,7 this study proposes a 
role for MerA in the reactivation of oxidised 4[Fe-S] cluster proteins by providing Fe2+.   
A sequence comparison of YpdA to that of a known TrxR protein showed a fundamental 
disparity between the proteins: YpdA lacked the active site CxxC motif associated with 
thioredoxin reductase function.4 Additionally, the protein displayed a four residue insert 
within the NADPH-binding domain, suggesting that it may be unable to bind the cofactor. 
Although anaerobic titrations of YpdA with NADPH disproved any difficulty binding the 
cofactor, the missing active site Cys pair gave pause to the protein’s potential for disulfide 
reduction activity. 
Assaying YpdA with the LMW thiols CoAD, BSSB and pantethine yielded no measurable 
disulfide reductase activity. Concern that the protein may be unable to function without an 
interacting partner lead to a new strategy: providing YpdA with a generic Trx partner, in the 
form of the characterised TrxA. Under these conditions, no reduction of the thiol disulfides 
was detected.  
Based on the results, this study can conclude that YpdA is not a direct BSSB reductase, as 
suggested by several studies.3, 5 However, the protein may interact with one of the proposed 
“bacilliredoxins” to reduce BSSB in a manner resembling that of the Grx/GSH/GR system.5 
Further work will therefore be necessary in order to draw a final conclusion on the potential 
activity of YpdA. 
5.3 Assessing the activity of the S. aureus thioredoxin system towards LMW 
thiol disulfides  
 
In Chapter 4, the TrxB and TrxA proteins were assayed with disulfides of LMW thiols known 
to be involved in S. aureus redox balance homeostasis, namely CoA and BSH. The 
thioredoxin system was shown to successfully reduce the disulfide forms of both 
compounds. For CoAD in particular, the proteins demonstrated a much lower affinity for the 
compound than that of CoADR, indicating that they are not primarily involved in such a 
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reaction. Additionally, the thioredoxin system was found to reduce the compound pantethine, 
a metabolic precursor and breakdown product of CoA. This study thus concludes that the 
thioredoxin system of S. aureus demonstrates much substrate promiscuity. Such promiscuity 
affords the system a role in the maintenance of S. aureus redox balance beyond its usual 
roles associated with the reduction of essential proteins. Therefore, TrxB and TrxA may be 
able to function as a back-up system for redox balance in critical conditions. Together, these 
findings further highlight TrxB as a viable and important target for the development of novel 
antibiotics. 
5.4 Future work 
5.4.1 The role of MerA in 4[Fe-S] cluster protein reactivation 
 
The proposal that MerA may provide Fe2+ for the reactivation of 4[Fe-S] cluster proteins must 
be investigated. Future studies on this topic will involve the development of merA-null S. 
aureus mutants that may be subjected to oxidative stress, after which the 4[Fe-S] protein 
integrity may be assessed. Additionally, pull-down assay studies with the MerA protein will 
be conducted in order to establish any protein-protein interactions MerA may have in the 
cell. MerA’s iron reducing abilities will also be further tested with other Fe (III) compounds, 
such as Fe (III) citrate. 
5.4.2 The interacting partners of YpdA and its role with BSSB 
 
The proposed bacilliredoxins, YphP and YtxJ, will be cloned and purified for assays with 
YpdA. Basic assays with BSSB as a substrate will be conducted, providing YpdA with the 
putative bacilliredoxins as interacting partners. Additional FRET experiments may be 
conducted to assess any interaction between YpdA and the putative bacilliredoxins. Failing 
noticeable interaction, YpdA may be used as a bait protein in pull-down assays to identify 
any protein partners.  
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